这是一篇来自已证抗体库的有关人类 CD19的综述,是根据435篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合CD19 抗体。
CD19 同义词: B4; CVID3

BioLegend
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
BioLegend CD19抗体(BioLegend, 302210)被用于被用于流式细胞仪在人类样本上. Nature (2020) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 1:200; 图 1s1a
BioLegend CD19抗体(BioLegend, 302244)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 1s1a). elife (2019) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 图 1a
BioLegend CD19抗体(BioLegend, SJ25C1)被用于被用于流式细胞仪在人类样本上 (图 1a). Arthritis Res Ther (2019) ncbi
小鼠 单克隆(HIB19)
  • 其他; 人类; 图 4b
BioLegend CD19抗体(BioLegend, 302259)被用于被用于其他在人类样本上 (图 4b). Cell (2019) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 1:100; 图 2c
BioLegend CD19抗体(Miltenyi, 302256)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 2c). elife (2019) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 s8
BioLegend CD19抗体(BioLegend, HIB19)被用于被用于流式细胞仪在人类样本上 (图 s8). Nat Commun (2019) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 2 ug/ml; 图 s13
BioLegend CD19抗体(BioLegend, 302211)被用于被用于流式细胞仪在人类样本上浓度为2 ug/ml (图 s13). Science (2019) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 s7b
BioLegend CD19抗体(BioLegend, 302216)被用于被用于流式细胞仪在人类样本上 (图 s7b). J Clin Invest (2019) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 2a
BioLegend CD19抗体(Biolegend, 302225)被用于被用于流式细胞仪在人类样本上 (图 2a). elife (2019) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 9d
BioLegend CD19抗体(BioLegend, 302210)被用于被用于流式细胞仪在人类样本上 (图 9d). J Exp Med (2019) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 小鼠; 图 2d
BioLegend CD19抗体(BioLegend, HIB19)被用于被用于流式细胞仪在小鼠样本上 (图 2d). Ann Rheum Dis (2019) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 s3c
BioLegend CD19抗体(Biolegend, HIB19)被用于被用于流式细胞仪在人类样本上 (图 s3c). Transl Oncol (2019) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 1c
BioLegend CD19抗体(BioLegend, 302246)被用于被用于流式细胞仪在人类样本上 (图 1c). J Exp Med (2018) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 s6d
BioLegend CD19抗体(Biolegend, HIB19)被用于被用于流式细胞仪在人类样本上 (图 s6d). Cell (2018) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 s18b
BioLegend CD19抗体(Biolegend, HIB19)被用于被用于流式细胞仪在人类样本上 (图 s18b). Science (2018) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 小鼠; 1:60; 图 7a
BioLegend CD19抗体(BioLegend, HIB19)被用于被用于流式细胞仪在小鼠样本上浓度为1:60 (图 7a). J Virol (2018) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 s1
BioLegend CD19抗体(BioLegend, HIB19)被用于被用于流式细胞仪在人类样本上 (图 s1). J Clin Invest (2018) ncbi
小鼠 单克隆(HIB19)
  • 免疫细胞化学基因敲除验证; 人类; 图 5a
BioLegend CD19抗体(BioLegend, HIB19)被用于被用于免疫细胞化学基因敲除验证在人类样本上 (图 5a). EMBO J (2018) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 小鼠; 图 s13b
BioLegend CD19抗体(Biolegend, HIB19)被用于被用于流式细胞仪在小鼠样本上 (图 s13b). J Clin Invest (2018) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 6a
BioLegend CD19抗体(Biolegend, HIB19)被用于被用于流式细胞仪在人类样本上 (图 6a). Sci Rep (2018) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 4a
BioLegend CD19抗体(BioLegend, HIB19)被用于被用于流式细胞仪在人类样本上 (图 4a). Oncotarget (2018) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 1a
BioLegend CD19抗体(biolegend, HIB19)被用于被用于流式细胞仪在人类样本上 (图 1a). J Immunol (2017) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 s4a
BioLegend CD19抗体(BioLegend, HIB19)被用于被用于流式细胞仪在人类样本上 (图 s4a). J Immunol (2017) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 表 s1
BioLegend CD19抗体(BioLegend, 302232)被用于被用于流式细胞仪在人类样本上 (表 s1). Proc Natl Acad Sci U S A (2017) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 1a
BioLegend CD19抗体(BioLegend, HIB19)被用于被用于流式细胞仪在人类样本上 (图 1a). Sci Rep (2017) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
BioLegend CD19抗体(Biolegend, HIB19)被用于被用于流式细胞仪在人类样本上. Nature (2017) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 7c
BioLegend CD19抗体(BioLegend, 302232)被用于被用于流式细胞仪在人类样本上 (图 7c). Immunity (2017) ncbi
小鼠 单克隆(HIB19)
  • mass cytometry; 人类; 图 1h
BioLegend CD19抗体(Biolegend, HIB19)被用于被用于mass cytometry在人类样本上 (图 1h). Science (2017) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 st12
BioLegend CD19抗体(Biolegend, HIB19)被用于被用于流式细胞仪在人类样本上 (图 st12). Science (2017) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 1e
BioLegend CD19抗体(Biolegend, 302216)被用于被用于流式细胞仪在人类样本上 (图 1e). J Extracell Vesicles (2017) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 1a
BioLegend CD19抗体(BioLegend, 302234)被用于被用于流式细胞仪在人类样本上 (图 1a). J Autoimmun (2017) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 2e
BioLegend CD19抗体(BioLegend, 302206)被用于被用于流式细胞仪在人类样本上 (图 2e). Sci Rep (2017) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 s1a
BioLegend CD19抗体(BioLegend, HIB19)被用于被用于流式细胞仪在人类样本上 (图 s1a). J Cell Biol (2017) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 s3a
BioLegend CD19抗体(BioLegend, HIB19)被用于被用于流式细胞仪在人类样本上 (图 s3a). Sci Rep (2017) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 图 3a
BioLegend CD19抗体(BioLegend, 363029)被用于被用于流式细胞仪在人类样本上 (图 3a). Oncoimmunology (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 s1d
BioLegend CD19抗体(Biolegend, HIB19)被用于被用于流式细胞仪在人类样本上 (图 s1d). Clin Immunol (2017) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
BioLegend CD19抗体(Biolegend, HIB19)被用于被用于流式细胞仪在人类样本上. Sci Rep (2017) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 S1
BioLegend CD19抗体(Biolegend, 30221)被用于被用于流式细胞仪在人类样本上 (图 S1). Front Immunol (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 表 1
BioLegend CD19抗体(Biolegend, HIB19)被用于被用于流式细胞仪在人类样本上 (表 1). Cytometry A (2017) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 1a
BioLegend CD19抗体(Biolegend, HIB19)被用于被用于流式细胞仪在人类样本上 (图 1a). Proc Natl Acad Sci U S A (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 1c
BioLegend CD19抗体(BioLegend, HIB19)被用于被用于流式细胞仪在人类样本上 (图 1c). J Autoimmun (2017) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 2a
BioLegend CD19抗体(Biolegend, HIB19)被用于被用于流式细胞仪在人类样本上 (图 2a). J Clin Invest (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 1
BioLegend CD19抗体(BioLegend, HIB19)被用于被用于流式细胞仪在人类样本上 (图 1). Proc Natl Acad Sci U S A (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 1d
BioLegend CD19抗体(Biolegend, 302212)被用于被用于流式细胞仪在人类样本上 (图 1d). Cell (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
BioLegend CD19抗体(Biolegend, HIB19)被用于被用于流式细胞仪在人类样本上. Clin Immunol (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 1
BioLegend CD19抗体(Biolegend, HIB19)被用于被用于流式细胞仪在人类样本上 (图 1). J Interferon Cytokine Res (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 s6a
BioLegend CD19抗体(BioLegend, HIB19)被用于被用于流式细胞仪在人类样本上 (图 s6a). J Clin Invest (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 s5a
BioLegend CD19抗体(Biolegend, 302215)被用于被用于流式细胞仪在人类样本上 (图 s5a). Sci Rep (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 1
BioLegend CD19抗体(Biolegend, HIN19)被用于被用于流式细胞仪在人类样本上 (图 1). PLoS Negl Trop Dis (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 1:200; 表 s2
BioLegend CD19抗体(Biolegend, HIB19)被用于被用于流式细胞仪在人类样本上浓度为1:200 (表 s2). Nat Immunol (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
BioLegend CD19抗体(Biolegend, HIB19)被用于被用于流式细胞仪在人类样本上. PLoS Pathog (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 1a
BioLegend CD19抗体(Biolegend, HIB-19)被用于被用于流式细胞仪在人类样本上 (图 1a). J Allergy Clin Immunol (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
BioLegend CD19抗体(Biolegend, HIB19)被用于被用于流式细胞仪在人类样本上. elife (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 6a
BioLegend CD19抗体(BioLegend, HIB19)被用于被用于流式细胞仪在人类样本上 (图 6a). J Biol Chem (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 s5b
BioLegend CD19抗体(Biolegend, HIB19)被用于被用于流式细胞仪在人类样本上 (图 s5b). Eur J Immunol (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 猕猴
BioLegend CD19抗体(BioLegend, 302242)被用于被用于流式细胞仪在猕猴样本上. Nat Med (2016) ncbi
小鼠 单克隆(HIB19)
  • mass cytometry; 人类; 表 1, 2
BioLegend CD19抗体(Biolegend, HIB19)被用于被用于mass cytometry在人类样本上 (表 1, 2). Methods Mol Biol (2016) ncbi
小鼠 单克隆(HIB19)
  • 免疫细胞化学; 人类; 图 3
BioLegend CD19抗体(Biolegend, 302202)被用于被用于免疫细胞化学在人类样本上 (图 3). J Immunol Methods (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 1a
BioLegend CD19抗体(BioLegend, HIB19)被用于被用于流式细胞仪在人类样本上 (图 1a). Nat Immunol (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 表 1
BioLegend CD19抗体(BioLegend, HIB19)被用于被用于流式细胞仪在人类样本上 (表 1). J Immunol (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 小鼠; 图 6b
BioLegend CD19抗体(BioLegend, HIB19)被用于被用于流式细胞仪在小鼠样本上 (图 6b). J Exp Med (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 1b
BioLegend CD19抗体(BioLegend, HIB19)被用于被用于流式细胞仪在人类样本上 (图 1b). Arthritis Rheumatol (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 1d
BioLegend CD19抗体(biolegend, HIB 19)被用于被用于流式细胞仪在人类样本上 (图 1d). Oncotarget (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 1
BioLegend CD19抗体(Biolegend, HIB19)被用于被用于流式细胞仪在人类样本上 (图 1). J Immunol (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 表 s1
BioLegend CD19抗体(Biolegend, 302210)被用于被用于流式细胞仪在人类样本上 (表 s1). Stem Cells (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 小鼠; 1:100
BioLegend CD19抗体(BioLegend, HIB19)被用于被用于流式细胞仪在小鼠样本上浓度为1:100. Nat Commun (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
BioLegend CD19抗体(BioLegend, HIB19)被用于被用于流式细胞仪在人类样本上. J Immunol (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 1a
BioLegend CD19抗体(biolegend, HIB19)被用于被用于流式细胞仪在人类样本上 (图 1a). J Immunol (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 8b
BioLegend CD19抗体(Biolegend,, 302228)被用于被用于流式细胞仪在人类样本上 (图 8b). PLoS ONE (2015) ncbi
小鼠 单克隆(HIB19)
BioLegend CD19抗体(Biolegend, 302219)被用于. Proc Natl Acad Sci U S A (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 5
BioLegend CD19抗体(BioLegend, HIB19)被用于被用于流式细胞仪在人类样本上 (图 5). PLoS Pathog (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 s2
BioLegend CD19抗体(Biolegend, 302205)被用于被用于流式细胞仪在人类样本上 (图 s2). Oncogene (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 1
BioLegend CD19抗体(Biolegend, 302216)被用于被用于流式细胞仪在人类样本上 (图 1). PLoS ONE (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 1
BioLegend CD19抗体(BioLegend, H1B19)被用于被用于流式细胞仪在人类样本上 (图 1). Oncotarget (2015) ncbi
小鼠 单克隆(HIB19)
BioLegend CD19抗体(Biolegend, HIB19)被用于. Clin Exp Immunol (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
BioLegend CD19抗体(BioLegend, 302216)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 1:200
BioLegend CD19抗体(Biolegend, HIB19)被用于被用于流式细胞仪在人类样本上浓度为1:200. J Immunol Methods (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
BioLegend CD19抗体(Biolegend, 302208)被用于被用于流式细胞仪在人类样本上. Blood Cancer J (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 5
BioLegend CD19抗体(BioLegend, HIB19)被用于被用于流式细胞仪在人类样本上 (图 5). J Exp Med (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 s2
BioLegend CD19抗体(biolegend, 302235)被用于被用于流式细胞仪在人类样本上 (图 s2). PLoS Pathog (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 5
BioLegend CD19抗体(Biolegend, # 302205)被用于被用于流式细胞仪在人类样本上 (图 5). Biomaterials (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
BioLegend CD19抗体(Biolegend, clone HIB19)被用于被用于流式细胞仪在人类样本上. Clin Vaccine Immunol (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 表 s1
BioLegend CD19抗体(Biolegend, HiB19)被用于被用于流式细胞仪在人类样本上 (表 s1). PLoS ONE (2015) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 表 s1
BioLegend CD19抗体(Biolegend, SJ25C1)被用于被用于流式细胞仪在人类样本上 (表 s1). PLoS ONE (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
BioLegend CD19抗体(Biolegend, 302226)被用于被用于流式细胞仪在人类样本上. Cytometry A (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
BioLegend CD19抗体(Biolegend, 302223)被用于被用于流式细胞仪在人类样本上. Hum Immunol (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 1
BioLegend CD19抗体(Biolegend, HIB19)被用于被用于流式细胞仪在人类样本上 (图 1). Int Immunol (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 1
BioLegend CD19抗体(Biolegend, HIB19)被用于被用于流式细胞仪在人类样本上 (图 1). J Exp Med (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 1
BioLegend CD19抗体(Biolegend, HIB19)被用于被用于流式细胞仪在人类样本上 (图 1). J Infect Dis (2015) ncbi
小鼠 单克隆(HIB19)
BioLegend CD19抗体(BioLegend, HIB19)被用于. Blood (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 小鼠; 1:100
BioLegend CD19抗体(BioLegend, 302225)被用于被用于流式细胞仪在小鼠样本上浓度为1:100. PLoS ONE (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
BioLegend CD19抗体(BioLegend, HIB19)被用于被用于流式细胞仪在人类样本上. J Immunol (2015) ncbi
小鼠 单克隆(HIB19)
BioLegend CD19抗体(Biolegend, 302217)被用于. J Vis Exp (2014) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
BioLegend CD19抗体(BioLegend, HIB19)被用于被用于流式细胞仪在人类样本上. Blood (2014) ncbi
小鼠 单克隆(HIB19)
BioLegend CD19抗体(BioLegend, HIB19)被用于. J Exp Med (2014) ncbi
小鼠 单克隆(HIB19)
BioLegend CD19抗体(BioLegend, HIB19)被用于. Nat Commun (2014) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
BioLegend CD19抗体(Biolegend, HIB19)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 表 1
BioLegend CD19抗体(Biolegend, HIB19)被用于被用于流式细胞仪在人类样本上 (表 1). Nat Immunol (2014) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
BioLegend CD19抗体(BioLegend, 302206)被用于被用于流式细胞仪在人类样本上. Nat Med (2014) ncbi
赛默飞世尔
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 图 2a
赛默飞世尔 CD19抗体(ThermoFisher, 48-0198-42)被用于被用于流式细胞仪在人类样本上 (图 2a). Cell (2019) ncbi
brown rat 单克隆(6OMP31)
  • 免疫组化-石蜡切片; 小鼠; 图 6d
赛默飞世尔 CD19抗体(Invitrogen, 60MP31)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 6d). J Clin Invest (2019) ncbi
小鼠 单克隆(HD37)
  • 流式细胞仪; 人类; 图 1c
赛默飞世尔 CD19抗体(Thermo Fisher, MA1-34005)被用于被用于流式细胞仪在人类样本上 (图 1c). Mol Cell Biol (2018) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 s1a
赛默飞世尔 CD19抗体(eBioscience, 48-0199-42)被用于被用于流式细胞仪在人类样本上 (图 s1a). J Clin Invest (2018) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 8a
赛默飞世尔 CD19抗体(eBioscience, 11-0199-42)被用于被用于流式细胞仪在人类样本上 (图 8a). Nat Commun (2018) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 1a
赛默飞世尔 CD19抗体(eBioscience, HIB19)被用于被用于流式细胞仪在人类样本上 (图 1a). J Immunol (2018) ncbi
brown rat 单克隆(6OMP31)
  • 免疫组化-石蜡切片; 小鼠; 1:1000; 图 2
赛默飞世尔 CD19抗体(ThermoFisher, 6OMP31)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:1000 (图 2). J Immunol (2018) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 表 s1
赛默飞世尔 CD19抗体(eBioscience, 17-0199-73)被用于被用于流式细胞仪在人类样本上 (表 s1). Proc Natl Acad Sci U S A (2017) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类; 1:100; 图 S5a
赛默飞世尔 CD19抗体(Invitrogen, MHCD1910)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 S5a). Nat Commun (2017) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 小鼠; 图 s4
赛默飞世尔 CD19抗体(Invitrogen, SJ25-C1)被用于被用于流式细胞仪在小鼠样本上 (图 s4). J Clin Invest (2017) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 2c
赛默飞世尔 CD19抗体(eBiosciences, HIB19)被用于被用于流式细胞仪在人类样本上 (图 2c). PLoS Pathog (2016) ncbi
小鼠 单克隆(UCHT1, HIB19)
赛默飞世尔 CD19抗体(eBioscience, UCHT1)被用于. Leukemia (2017) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类; 图 2a
赛默飞世尔 CD19抗体(Invitrogen, SJ25-C1)被用于被用于流式细胞仪在人类样本上 (图 2a). Cytotherapy (2017) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 2e
赛默飞世尔 CD19抗体(eBiosciences, HIB19)被用于被用于流式细胞仪在人类样本上 (图 2e). J Immunol (2016) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类
赛默飞世尔 CD19抗体(Thermo Scientific, SJ25-C1)被用于被用于流式细胞仪在人类样本上. Clin Immunol (2016) ncbi
小鼠 单克隆(UCHT1, HIB19)
赛默飞世尔 CD19抗体(Invitrogen, UCHT1)被用于. AIDS Res Hum Retroviruses (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 s5
赛默飞世尔 CD19抗体(eBioscience, H1B19)被用于被用于流式细胞仪在人类样本上 (图 s5). PLoS Pathog (2016) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 图 st9
赛默飞世尔 CD19抗体(eBioscience, SJ25C1)被用于被用于流式细胞仪在人类样本上 (图 st9). JCI Insight (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 2
赛默飞世尔 CD19抗体(eBioscience, 11-0199-41)被用于被用于流式细胞仪在人类样本上 (图 2). Stem Cell Reports (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD19抗体(eBioscience, 48-0199)被用于被用于流式细胞仪在人类样本上 (图 1). Nat Commun (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 1a
赛默飞世尔 CD19抗体(eBiosciences, HIB19)被用于被用于流式细胞仪在人类样本上 (图 1a). J Immunol (2016) ncbi
小鼠 单克隆(UCHT1, HIB19)
赛默飞世尔 CD19抗体(Invitrogen, UCHT1)被用于. PLoS ONE (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 1:50; 图 1e
赛默飞世尔 CD19抗体(eBiosciences, 12-0199)被用于被用于流式细胞仪在人类样本上浓度为1:50 (图 1e). Nat Cell Biol (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 1:200; 图 7
赛默飞世尔 CD19抗体(eBioscience, 13-0199)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 7). Haematologica (2016) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类; 图 4
赛默飞世尔 CD19抗体(生活技术, SJ25-C1)被用于被用于流式细胞仪在人类样本上 (图 4). Ann Clin Transl Neurol (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 1:50
赛默飞世尔 CD19抗体(ebioscience, HIB19)被用于被用于流式细胞仪在人类样本上浓度为1:50. PLoS ONE (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 1:100; 图 s1a
赛默飞世尔 CD19抗体(eBioscience, 1170199-42)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 s1a). Acta Neuropathol (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 1b
赛默飞世尔 CD19抗体(eBioscience, 17-0199)被用于被用于流式细胞仪在人类样本上 (图 1b). Stem Cells Int (2016) ncbi
小鼠 单克隆(UCHT1, HIB19)
赛默飞世尔 CD19抗体(eBioscience, UCHT1)被用于. Immunol Res (2016) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD19抗体(Caltag, SJ25-C1)被用于被用于流式细胞仪在人类样本上 (图 1). Arch Med Res (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 7
赛默飞世尔 CD19抗体(eBioscience, HIB19)被用于被用于流式细胞仪在人类样本上 (图 7). Eur J Immunol (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 小鼠
赛默飞世尔 CD19抗体(eBioscience, H1B19)被用于被用于流式细胞仪在小鼠样本上. Nat Chem Biol (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 4b
赛默飞世尔 CD19抗体(eBioscience, 56-0199-42)被用于被用于流式细胞仪在人类样本上 (图 4b). Hum Vaccin Immunother (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 s3
赛默飞世尔 CD19抗体(eBioscience, HIB19)被用于被用于流式细胞仪在人类样本上 (图 s3). J Exp Med (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
赛默飞世尔 CD19抗体(eBioscience, 25-0199)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 4
赛默飞世尔 CD19抗体(eBioscience, HIB19)被用于被用于流式细胞仪在人类样本上 (图 4). Leukemia (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 S1
赛默飞世尔 CD19抗体(eBioscience, HIB19)被用于被用于流式细胞仪在人类样本上 (图 S1). J Neuroinflammation (2015) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类; 图 2
赛默飞世尔 CD19抗体(Invitrogen, SJ25-C1)被用于被用于流式细胞仪在人类样本上 (图 2). Bone Marrow Transplant (2015) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD19抗体(Invitrogen, SJ25-C1)被用于被用于流式细胞仪在人类样本上 (图 1). J Exp Med (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD19抗体(eBioscience, Hib19)被用于被用于流式细胞仪在人类样本上 (图 1). Blood (2015) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类
赛默飞世尔 CD19抗体(ebioscience, 12-0198)被用于被用于流式细胞仪在人类样本上. Med Oncol (2015) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类
赛默飞世尔 CD19抗体(Invitrogen, SJ25-C1)被用于被用于流式细胞仪在人类样本上. Stem Cell Res (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
赛默飞世尔 CD19抗体(eBioscience, HIB19)被用于被用于流式细胞仪在人类样本上. Immun Inflamm Dis (2014) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
赛默飞世尔 CD19抗体(eBioscience, 25-0199)被用于被用于流式细胞仪在人类样本上. J Pediatr Surg (2014) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
赛默飞世尔 CD19抗体(eBioscience, HIB19)被用于被用于流式细胞仪在人类样本上. J Allergy Clin Immunol (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 表 3
赛默飞世尔 CD19抗体(eBioscience, HIB19)被用于被用于流式细胞仪在人类样本上 (表 3). Cytometry B Clin Cytom (2014) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
赛默飞世尔 CD19抗体(eBioscience, HIB19)被用于被用于流式细胞仪在人类样本上. Chest (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
赛默飞世尔 CD19抗体(e-Bioscience, HIB19)被用于被用于流式细胞仪在人类样本上. Nat Commun (2014) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
赛默飞世尔 CD19抗体(eBioscience, HIB19)被用于被用于流式细胞仪在人类样本上. J Hepatol (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
赛默飞世尔 CD19抗体(eBioscience, HIB19)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类
赛默飞世尔 CD19抗体(生活技术, MHCD1901)被用于被用于流式细胞仪在人类样本上. Cytometry A (2014) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
赛默飞世尔 CD19抗体(eBioscience, HIB19)被用于被用于流式细胞仪在人类样本上. J Exp Med (2014) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类
赛默飞世尔 CD19抗体(Invitrogen, SJ25-C1)被用于被用于流式细胞仪在人类样本上. Leukemia (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
赛默飞世尔 CD19抗体(eBioscience, HIB19)被用于被用于流式细胞仪在人类样本上. J Infect Dis (2014) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
赛默飞世尔 CD19抗体(eBiosciences, HIB19)被用于被用于流式细胞仪在人类样本上. J Clin Immunol (2014) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
赛默飞世尔 CD19抗体(eBioscience, HIB19)被用于被用于流式细胞仪在人类样本上. Biomed Res Int (2014) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
赛默飞世尔 CD19抗体(eBioscience, HIB19)被用于被用于流式细胞仪在人类样本上. Int J Cancer (2014) ncbi
小鼠 单克隆(UCHT1, HIB19)
赛默飞世尔 CD19抗体(Invitrogen, UCHT1)被用于. PLoS Pathog (2014) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类
赛默飞世尔 CD19抗体(Invitrogen, SJ25-C1)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
赛默飞世尔 CD19抗体(eBioscience, HIB19)被用于被用于流式细胞仪在人类样本上. PLoS Pathog (2014) ncbi
小鼠 单克隆(UCHT1, HIB19)
赛默飞世尔 CD19抗体(eBioscience, UCHT1)被用于. J Infect Dis (2014) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类; 1:10; 图 4
赛默飞世尔 CD19抗体(Invitrogen, SJ25-C1)被用于被用于流式细胞仪在人类样本上浓度为1:10 (图 4). Drug Metab Dispos (2014) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类
赛默飞世尔 CD19抗体(Invitrogen, noca)被用于被用于流式细胞仪在人类样本上. Infect Immun (2013) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类; 图 9
赛默飞世尔 CD19抗体(Invitrogen, MHCD1928)被用于被用于流式细胞仪在人类样本上 (图 9). J Virol (2013) ncbi
小鼠 单克隆(SJ25-C1)
  • 免疫细胞化学; 人类; 图 1
赛默飞世尔 CD19抗体(Invitrogen, clone SJ25-C1)被用于被用于免疫细胞化学在人类样本上 (图 1). Hum Gene Ther (2013) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD19抗体(Invitrogen, clone SJ25-C1)被用于被用于流式细胞仪在人类样本上 (图 1). J Immunol (2013) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类
赛默飞世尔 CD19抗体(Invitrogen, SJ25-C1)被用于被用于流式细胞仪在人类样本上. J Biol Chem (2012) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD19抗体(Invitrogen, MHCD1929)被用于被用于流式细胞仪在人类样本上 (图 1). Oncoimmunology (2012) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
赛默飞世尔 CD19抗体(eBioscience, HIB19)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2012) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类
赛默飞世尔 CD19抗体(Invitrogen, clone SJ25-C1)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2012) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类; 图 3
赛默飞世尔 CD19抗体(InVitrogen, SJ25-C1)被用于被用于流式细胞仪在人类样本上 (图 3). PLoS ONE (2012) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类; 图 2a
赛默飞世尔 CD19抗体(Invitrogen, SJ25-C1)被用于被用于流式细胞仪在人类样本上 (图 2a). Sci Transl Med (2012) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类; 图 3
赛默飞世尔 CD19抗体(Invitrogen, MHCD1928)被用于被用于流式细胞仪在人类样本上 (图 3). Int Immunol (2012) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; African green monkey; 图 3
赛默飞世尔 CD19抗体(Invitrogen, SJ25-C1)被用于被用于流式细胞仪在African green monkey样本上 (图 3). PLoS ONE (2011) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类; 图 2
赛默飞世尔 CD19抗体(Caltag, ST25-C1)被用于被用于流式细胞仪在人类样本上 (图 2). J Infect Dis (2011) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类; 图 8
赛默飞世尔 CD19抗体(Caltag, clone SJ25-C1)被用于被用于流式细胞仪在人类样本上 (图 8). J Immunol (2011) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD19抗体(Invitrogen, clone SJ25-C1)被用于被用于流式细胞仪在人类样本上 (图 1). Mol Ther (2011) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类; 图 1, 2
赛默飞世尔 CD19抗体(Caltag, SJ25-C)被用于被用于流式细胞仪在人类样本上 (图 1, 2). Cancer Res (2011) ncbi
小鼠 单克隆(SJ25-C1)
  • 免疫细胞化学; 人类
赛默飞世尔 CD19抗体(Invitrogen, SJ25-C1)被用于被用于免疫细胞化学在人类样本上. Clin Infect Dis (2011) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD19抗体(Invitrogen, MHCD1905)被用于被用于流式细胞仪在人类样本上 (图 1). Virus Res (2011) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD19抗体(Caltag, MHCD1918)被用于被用于流式细胞仪在人类样本上 (图 1). Cytometry B Clin Cytom (2010) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类; 图 4
赛默飞世尔 CD19抗体(Caltag, Clone SJ25-C1)被用于被用于流式细胞仪在人类样本上 (图 4). Leukemia (2010) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD19抗体(Invitrogen, MHCD1905)被用于被用于流式细胞仪在人类样本上 (图 1). J Interferon Cytokine Res (2010) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD19抗体(Caltag, SJ25-C1)被用于被用于流式细胞仪在人类样本上 (图 1). Int Arch Allergy Immunol (2010) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类
赛默飞世尔 CD19抗体(Invitrogen, MHCD1929)被用于被用于流式细胞仪在人类样本上. Nat Protoc (2010) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD19抗体(eBioscience, H1B19)被用于被用于流式细胞仪在人类样本上 (图 1). Hum Immunol (2010) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类; 图 3
赛默飞世尔 CD19抗体(Invitrogen, SJ25-C1)被用于被用于流式细胞仪在人类样本上 (图 3). Biotechnol J (2010) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD19抗体(Invitrogen, MHCD1905)被用于被用于流式细胞仪在人类样本上 (图 1). Biochem Biophys Res Commun (2009) ncbi
小鼠 单克隆(SJ25-C1)
赛默飞世尔 CD19抗体(Caltag, FJ25-C1)被用于. Blood (2009) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类
赛默飞世尔 CD19抗体(Caltag Laboratories, SJ25-C1)被用于被用于流式细胞仪在人类样本上. Cell Transplant (2009) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类; 1:20; 图 3
赛默飞世尔 CD19抗体(CalTag, clone MHCD1904)被用于被用于流式细胞仪在人类样本上浓度为1:20 (图 3). J Pathol (2009) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 猕猴
赛默飞世尔 CD19抗体(Invitrogen, SJ25-C1)被用于被用于流式细胞仪在猕猴样本上. J Med Primatol (2008) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类; 图 2a
赛默飞世尔 CD19抗体(Caltag, SJ25-C1)被用于被用于流式细胞仪在人类样本上 (图 2a). Nat Protoc (2008) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类
赛默飞世尔 CD19抗体(Caltag, SJ25-C1)被用于被用于流式细胞仪在人类样本上. Mol Immunol (2008) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类
赛默飞世尔 CD19抗体(Caltag, SJ25-C1)被用于被用于流式细胞仪在人类样本上. Cytometry B Clin Cytom (2008) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 猕猴
  • 流式细胞仪; 食蟹猴
赛默飞世尔 CD19抗体(Invitrogen, SJ25-C1)被用于被用于流式细胞仪在猕猴样本上 和 被用于流式细胞仪在食蟹猴样本上. Eur J Immunol (2008) ncbi
小鼠 单克隆(4G7)
  • 流式细胞仪; 人类; 图 4
赛默飞世尔 CD19抗体(Caltag, 4G7)被用于被用于流式细胞仪在人类样本上 (图 4). Microbes Infect (2008) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD19抗体(Caltag, SJ25-C1)被用于被用于流式细胞仪在人类样本上 (图 1). J Cell Physiol (2008) ncbi
小鼠 单克隆(4G7)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD19抗体(Caltag, 4G7)被用于被用于流式细胞仪在人类样本上 (图 1). Clin Exp Immunol (2007) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类
赛默飞世尔 CD19抗体(Caltag, SJ25-C1)被用于被用于流式细胞仪在人类样本上. Leukemia (2007) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类; 表 1
赛默飞世尔 CD19抗体(Caltag, SJ25-C1)被用于被用于流式细胞仪在人类样本上 (表 1). Blood (2007) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD19抗体(Caltag, sJ25-C1)被用于被用于流式细胞仪在人类样本上 (图 1). Rheumatology (Oxford) (2007) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类
赛默飞世尔 CD19抗体(Caltag, SJ25-C1)被用于被用于流式细胞仪在人类样本上. J Immunol (2006) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类
赛默飞世尔 CD19抗体(Caltag, SJ25-C1)被用于被用于流式细胞仪在人类样本上. Scand J Immunol (2006) ncbi
小鼠 单克隆(SJ25-C1)
  • 其他; 人类
赛默飞世尔 CD19抗体(Caltag, SJ25-C1)被用于被用于其他在人类样本上. Atherosclerosis (2007) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类
赛默飞世尔 CD19抗体(CALTAG, SJ25-C1)被用于被用于流式细胞仪在人类样本上. Int J Oncol (2006) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类
赛默飞世尔 CD19抗体(Caltag, SJ25-C1)被用于被用于流式细胞仪在人类样本上. Proc Natl Acad Sci U S A (2006) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类; 表 1
赛默飞世尔 CD19抗体(Caltag, SJ25-C1)被用于被用于流式细胞仪在人类样本上 (表 1). Haematologica (2006) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类
赛默飞世尔 CD19抗体(Caltag Laboratories, SJ25-C1)被用于被用于流式细胞仪在人类样本上. J Immunol (2006) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类; 图 4
赛默飞世尔 CD19抗体(Caltag, SJ25-C1)被用于被用于流式细胞仪在人类样本上 (图 4). Blood (2006) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类
赛默飞世尔 CD19抗体(Caltag, SJ25-C1)被用于被用于流式细胞仪在人类样本上. Cancer Immunol Immunother (2006) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类
赛默飞世尔 CD19抗体(Caltag, SJ25-C1)被用于被用于流式细胞仪在人类样本上. Methods Mol Biol (2005) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类
赛默飞世尔 CD19抗体(Caltag, SJ25-C1)被用于被用于流式细胞仪在人类样本上. Cytometry A (2005) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类
赛默飞世尔 CD19抗体(Caltag, SJ25-C1)被用于被用于流式细胞仪在人类样本上. Scand J Gastroenterol (2004) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类
赛默飞世尔 CD19抗体(Caltag, SJ25-C1)被用于被用于流式细胞仪在人类样本上. J Exp Med (2004) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类
赛默飞世尔 CD19抗体(Caltag, SJ25-C1)被用于被用于流式细胞仪在人类样本上. Circulation (2004) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类
赛默飞世尔 CD19抗体(Caltag, SJ25-C1)被用于被用于流式细胞仪在人类样本上. Int Immunol (2004) ncbi
小鼠 单克隆(SJ25-C1)
  • 抑制或激活实验; 人类; 图 1
赛默飞世尔 CD19抗体(Caltag, SJ25-C1)被用于被用于抑制或激活实验在人类样本上 (图 1). Atherosclerosis (2004) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类; 图 1
  • 流式细胞仪; 小鼠; 图 1
赛默飞世尔 CD19抗体(Caltag, SJ25-C1)被用于被用于流式细胞仪在人类样本上 (图 1) 和 被用于流式细胞仪在小鼠样本上 (图 1). Blood (2004) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类; 表 1
赛默飞世尔 CD19抗体(Caltag, SJ25/C1)被用于被用于流式细胞仪在人类样本上 (表 1). Atherosclerosis (2004) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类; 表 1
赛默飞世尔 CD19抗体(Caltag, SJ25-C1)被用于被用于流式细胞仪在人类样本上 (表 1). Haematologica (2004) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类; 表 1
赛默飞世尔 CD19抗体(Caltag, SJ25-C1)被用于被用于流式细胞仪在人类样本上 (表 1). J Immunol (2003) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类
赛默飞世尔 CD19抗体(Caltag, SJ25-C1)被用于被用于流式细胞仪在人类样本上. Cancer Immunol Immunother (2003) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类
赛默飞世尔 CD19抗体(Caltag, SJ25-C1)被用于被用于流式细胞仪在人类样本上. Proc Natl Acad Sci U S A (2003) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类
赛默飞世尔 CD19抗体(Caltag, SJ25-C1)被用于被用于流式细胞仪在人类样本上. Cytometry B Clin Cytom (2003) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类; 5 ug/ml
赛默飞世尔 CD19抗体(Caltag, SJ25-C1)被用于被用于流式细胞仪在人类样本上浓度为5 ug/ml. Blood (2001) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类; 图 4
赛默飞世尔 CD19抗体(Caltag, SJ25-C1)被用于被用于流式细胞仪在人类样本上 (图 4). Int Immunol (2001) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类; 图 2
赛默飞世尔 CD19抗体(Caltag, SJ35-C1)被用于被用于流式细胞仪在人类样本上 (图 2). Blood (2000) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD19抗体(Caltag, SJ25-C1)被用于被用于流式细胞仪在人类样本上 (图 1). Hum Immunol (2000) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD19抗体(Caltag, SJ25-C1)被用于被用于流式细胞仪在人类样本上 (图 1). Leuk Lymphoma (1999) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类
赛默飞世尔 CD19抗体(Caltag, SJ25-C1)被用于被用于流式细胞仪在人类样本上. Haematologica (1999) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类; 图 2
赛默飞世尔 CD19抗体(Caltag, SJ25-C1)被用于被用于流式细胞仪在人类样本上 (图 2). Leuk Res (1999) ncbi
小鼠 单克隆(4G7)
  • 流式细胞仪; 人类
赛默飞世尔 CD19抗体(Caltag, 4G7)被用于被用于流式细胞仪在人类样本上. Blood (1995) ncbi
艾博抗(上海)贸易有限公司
小鼠 单克隆(2E2B6B10)
  • 免疫细胞化学; 人类; 1:100; 图 8a
艾博抗(上海)贸易有限公司 CD19抗体(Abcam, ab31947)被用于被用于免疫细胞化学在人类样本上浓度为1:100 (图 8a). Nat Commun (2018) ncbi
小鼠 单克隆(CB19)
  • 流式细胞仪; 人类; 1:100; 图 S5a
艾博抗(上海)贸易有限公司 CD19抗体(Abcam, ab1168)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 S5a). Nat Commun (2017) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 图 1b
艾博抗(上海)贸易有限公司 CD19抗体(Abcam, SJ25-C1)被用于被用于流式细胞仪在人类样本上 (图 1b). Blood (2017) ncbi
小鼠 单克隆(2E2B6B10)
  • 流式细胞仪; 人类; 1:1000; 表 1
艾博抗(上海)贸易有限公司 CD19抗体(Abcam, ab31947)被用于被用于流式细胞仪在人类样本上浓度为1:1000 (表 1). Exp Ther Med (2016) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 图 s4b
艾博抗(上海)贸易有限公司 CD19抗体(Abcam, SJ25-C1)被用于被用于流式细胞仪在人类样本上 (图 s4b). J Immunol (2016) ncbi
domestic rabbit 单克隆(EPR5906)
  • 免疫组化-冰冻切片; 人类; 图 s1a
艾博抗(上海)贸易有限公司 CD19抗体(Abcam, ab134114)被用于被用于免疫组化-冰冻切片在人类样本上 (图 s1a). Arthritis Res Ther (2016) ncbi
小鼠 单克隆(2E2B6B10)
  • 免疫组化-石蜡切片; 人类; 表 2
艾博抗(上海)贸易有限公司 CD19抗体(Abcam, ab31947)被用于被用于免疫组化-石蜡切片在人类样本上 (表 2). Oncol Lett (2016) ncbi
小鼠 单克隆(2E2B6B10)
  • 酶联免疫吸附测定; 人类
艾博抗(上海)贸易有限公司 CD19抗体(Abcam, 2E2B6B10)被用于被用于酶联免疫吸附测定在人类样本上. J Transl Med (2013) ncbi
美天旎
小鼠 单克隆(LT19)
  • 流式细胞仪; 人类; 图 2c
美天旎 CD19抗体(Miltenyi Biotech, LT19)被用于被用于流式细胞仪在人类样本上 (图 2c). Sci Rep (2018) ncbi
小鼠 单克隆(LT19)
  • 流式细胞仪; 人类; 图 s7a
美天旎 CD19抗体(Miltenyi, LT19)被用于被用于流式细胞仪在人类样本上 (图 s7a). Front Immunol (2017) ncbi
小鼠 单克隆(LT19)
  • 流式细胞仪; 人类; 图 1a
美天旎 CD19抗体(Miltenyi Biotec, LT19)被用于被用于流式细胞仪在人类样本上 (图 1a). J Immunol (2017) ncbi
小鼠 单克隆(LT19)
  • 流式细胞仪; 人类; 图 4b
美天旎 CD19抗体(Miltenyi Biotec, LT19)被用于被用于流式细胞仪在人类样本上 (图 4b). Front Immunol (2017) ncbi
小鼠 单克隆(LT19)
  • 流式细胞仪; 人类; 图 1b
美天旎 CD19抗体(Miltenyi Biotec, LT19)被用于被用于流式细胞仪在人类样本上 (图 1b). Br J Cancer (2016) ncbi
小鼠 单克隆(LT19)
  • 流式细胞仪; 人类; 表 1
美天旎 CD19抗体(Miltenyi Biotec, LT19)被用于被用于流式细胞仪在人类样本上 (表 1). Methods Mol Biol (2016) ncbi
伯乐(Bio-Rad)公司
小鼠 单克隆(LT19)
  • 流式细胞仪; 人类; 1:10; 图 2a
伯乐(Bio-Rad)公司 CD19抗体(Bio-Rad, LT19)被用于被用于流式细胞仪在人类样本上浓度为1:10 (图 2a). J Leukoc Biol (2017) ncbi
小鼠 单克隆(SJ25-C1)
  • 流式细胞仪; 人类
伯乐(Bio-Rad)公司 CD19抗体(AbD Serotec, SJ25-C1)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(LE-CD19)
  • 免疫组化-石蜡切片; 人类
伯乐(Bio-Rad)公司 CD19抗体(Serotec, MCA2454)被用于被用于免疫组化-石蜡切片在人类样本上. Leuk Lymphoma (2014) ncbi
小鼠 单克隆(LT19)
  • 流式细胞仪; 人类; 图 1
伯乐(Bio-Rad)公司 CD19抗体(ABD Serotec, MCA1940A488)被用于被用于流式细胞仪在人类样本上 (图 1). Cytometry B Clin Cytom (2014) ncbi
小鼠 单克隆(LT19)
  • 流式细胞仪; 人类
伯乐(Bio-Rad)公司 CD19抗体(AbD Serotec, MCA1940F)被用于被用于流式细胞仪在人类样本上. MAbs (2012) ncbi
北京傲锐东源
小鼠 单克隆(OTI2F6)
  • 免疫细胞化学; 小鼠; 图 1b
北京傲锐东源 CD19抗体(OriGene, TA506240)被用于被用于免疫细胞化学在小鼠样本上 (图 1b). elife (2018) ncbi
安迪生物R&D
小鼠 单克隆(4G7-2E3)
  • 其他; 人类; 图 2b
安迪生物R&D CD19抗体(R&D Systems, MAB4867)被用于被用于其他在人类样本上 (图 2b). J Immunol Methods (2016) ncbi
小鼠 单克隆(4G7-2E3)
  • 流式细胞仪; 小鼠; 1:100; 图 2
  • 流式细胞仪; 人类; 1:100; 图 2
安迪生物R&D CD19抗体(R&D System, FAB4867A)被用于被用于流式细胞仪在小鼠样本上浓度为1:100 (图 2) 和 被用于流式细胞仪在人类样本上浓度为1:100 (图 2). Nat Commun (2016) ncbi
小鼠 单克隆(4G7-2E3)
  • 其他; 人类; 图 2
安迪生物R&D CD19抗体(R&D Systems, MAB4867)被用于被用于其他在人类样本上 (图 2). J Extracell Vesicles (2015) ncbi
圣克鲁斯生物技术
小鼠 单克隆(HD37)
  • 流式细胞仪; 人类; 图 s1c
圣克鲁斯生物技术 CD19抗体(Santa Cruz, HD37)被用于被用于流式细胞仪在人类样本上 (图 s1c). Cell Rep (2016) ncbi
小鼠 单克隆(HD37)
  • 免疫细胞化学; 人类
圣克鲁斯生物技术 CD19抗体(Santa Cruz Biotechnology, HD37)被用于被用于免疫细胞化学在人类样本上. J Cell Physiol (2014) ncbi
贝克曼库尔特实验系统(苏州)有限公司
小鼠 单克隆(J3-119)
  • 流式细胞仪; 人类; 图 3b
贝克曼库尔特实验系统(苏州)有限公司 CD19抗体(Beckman Coulter, J3-119)被用于被用于流式细胞仪在人类样本上 (图 3b). Front Immunol (2019) ncbi
小鼠 单克隆(J3-119)
  • 流式细胞仪; 人类; 图 s18
贝克曼库尔特实验系统(苏州)有限公司 CD19抗体(Beckman Coulter, J3-119)被用于被用于流式细胞仪在人类样本上 (图 s18). J Clin Invest (2019) ncbi
小鼠 单克隆(J3-119)
  • 流式细胞仪; 人类; 图 4a
贝克曼库尔特实验系统(苏州)有限公司 CD19抗体(Beckman Coulter, J3-119)被用于被用于流式细胞仪在人类样本上 (图 4a). J Clin Invest (2018) ncbi
小鼠 单克隆(J3-119)
  • 流式细胞仪; 人类; 图 s3f
贝克曼库尔特实验系统(苏州)有限公司 CD19抗体(Beckman Coulter, J3-119)被用于被用于流式细胞仪在人类样本上 (图 s3f). J Clin Invest (2017) ncbi
小鼠 单克隆(HD237)
  • 流式细胞仪; 人类; 图 1
贝克曼库尔特实验系统(苏州)有限公司 CD19抗体(Beckman Coulter, 6604551)被用于被用于流式细胞仪在人类样本上 (图 1). Exp Ther Med (2017) ncbi
小鼠 单克隆(J3-119)
  • 流式细胞仪; 人类; 表 2
贝克曼库尔特实验系统(苏州)有限公司 CD19抗体(Beckman Coulter, IM3628)被用于被用于流式细胞仪在人类样本上 (表 2). J Immunol Methods (2017) ncbi
小鼠 单克隆(J3-119)
  • 流式细胞仪; 人类; 图 2c
贝克曼库尔特实验系统(苏州)有限公司 CD19抗体(Beckman Coulter, J3-119)被用于被用于流式细胞仪在人类样本上 (图 2c). Clin Immunol (2017) ncbi
小鼠 单克隆(J3-119)
  • 流式细胞仪; 人类; 1:25; 图 4
贝克曼库尔特实验系统(苏州)有限公司 CD19抗体(Beckman Coulter, J3-119)被用于被用于流式细胞仪在人类样本上浓度为1:25 (图 4). Nat Commun (2016) ncbi
小鼠 单克隆(J3-119)
  • 流式细胞仪; 人类; 图 1a
贝克曼库尔特实验系统(苏州)有限公司 CD19抗体(Beckman Coulter, J3-119)被用于被用于流式细胞仪在人类样本上 (图 1a). Cytometry B Clin Cytom (2018) ncbi
小鼠 单克隆(J3-119)
  • 流式细胞仪; 人类; 图 2a
贝克曼库尔特实验系统(苏州)有限公司 CD19抗体(Beckman-Coulter, J3.119)被用于被用于流式细胞仪在人类样本上 (图 2a). Sci Rep (2016) ncbi
小鼠 单克隆(J3-119)
  • 流式细胞仪; 人类; 图 s3c
贝克曼库尔特实验系统(苏州)有限公司 CD19抗体(Beckman Coulter, J3-119)被用于被用于流式细胞仪在人类样本上 (图 s3c). Science (2016) ncbi
小鼠 单克隆(J3-119)
  • 流式细胞仪; 人类; 图 s2
贝克曼库尔特实验系统(苏州)有限公司 CD19抗体(Beckman Coulter, J3-119)被用于被用于流式细胞仪在人类样本上 (图 s2). Sci Rep (2016) ncbi
小鼠 单克隆(J3-119)
  • 流式细胞仪; 猕猴; 1:30
贝克曼库尔特实验系统(苏州)有限公司 CD19抗体(Beckman Coulter, IM2643U)被用于被用于流式细胞仪在猕猴样本上浓度为1:30. Nat Med (2016) ncbi
小鼠 单克隆(J3-119)
  • 其他; 人类; 200 ug/ml; 图 2
贝克曼库尔特实验系统(苏州)有限公司 CD19抗体(Beckman Coulter, IM1313)被用于被用于其他在人类样本上浓度为200 ug/ml (图 2). J Extracell Vesicles (2016) ncbi
小鼠 单克隆(J3-119)
  • 流式细胞仪; 人类; 表 1
贝克曼库尔特实验系统(苏州)有限公司 CD19抗体(Beckman Coulter, J3-119)被用于被用于流式细胞仪在人类样本上 (表 1). Int J Lab Hematol (2016) ncbi
小鼠 单克隆(J3-119)
  • 其他; 人类; 图 st1
  • 流式细胞仪; 人类; 图 st3
贝克曼库尔特实验系统(苏州)有限公司 CD19抗体(Beckman Coulter, J3-119)被用于被用于其他在人类样本上 (图 st1) 和 被用于流式细胞仪在人类样本上 (图 st3). Mol Cell Proteomics (2016) ncbi
小鼠 单克隆(J3-119)
  • 流式细胞仪; African green monkey; 图 4
贝克曼库尔特实验系统(苏州)有限公司 CD19抗体(Beckman Coulter, J3-119)被用于被用于流式细胞仪在African green monkey样本上 (图 4). J Immunol (2016) ncbi
小鼠 单克隆(J3-119)
  • 流式细胞仪; 人类; 表 1
贝克曼库尔特实验系统(苏州)有限公司 CD19抗体(Beckman Coulter, J3-119)被用于被用于流式细胞仪在人类样本上 (表 1). Cytometry B Clin Cytom (2016) ncbi
小鼠 单克隆(J3-119)
  • 流式细胞仪; 人类; 表 4
贝克曼库尔特实验系统(苏州)有限公司 CD19抗体(Beckman Coulter, J3.119)被用于被用于流式细胞仪在人类样本上 (表 4). Cytometry B Clin Cytom (2015) ncbi
小鼠 单克隆(J3-119)
  • 流式细胞仪; 人类
贝克曼库尔特实验系统(苏州)有限公司 CD19抗体(Beckman-Coulter, J3-119)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(J3-119)
  • 流式细胞仪; 人类
贝克曼库尔特实验系统(苏州)有限公司 CD19抗体(Beckman-Coulter, J3-119)被用于被用于流式细胞仪在人类样本上. Front Immunol (2014) ncbi
小鼠 单克隆(J3-119)
  • 流式细胞仪; 人类
贝克曼库尔特实验系统(苏州)有限公司 CD19抗体(Beckman Coulter, J3-119)被用于被用于流式细胞仪在人类样本上. J Leukoc Biol (2014) ncbi
小鼠 单克隆(J3-119)
  • 流式细胞仪; 人类
贝克曼库尔特实验系统(苏州)有限公司 CD19抗体(Beckman Coulter, J3-119)被用于被用于流式细胞仪在人类样本上. J Exp Med (2014) ncbi
小鼠 单克隆(J3-119)
  • 流式细胞仪; 猕猴
贝克曼库尔特实验系统(苏州)有限公司 CD19抗体(Beckman Coulter, J3-119)被用于被用于流式细胞仪在猕猴样本上. Clin Immunol (2014) ncbi
小鼠 单克隆(J3-119)
  • 流式细胞仪; 人类
贝克曼库尔特实验系统(苏州)有限公司 CD19抗体(Beckman Coulter, J3-119)被用于被用于流式细胞仪在人类样本上. Clin Exp Immunol (2014) ncbi
小鼠 单克隆(J3-119)
  • 流式细胞仪; 人类; 图 2
贝克曼库尔特实验系统(苏州)有限公司 CD19抗体(Beckman Coulter, IM3628U)被用于被用于流式细胞仪在人类样本上 (图 2). Cytometry B Clin Cytom (2014) ncbi
丹科医疗器械技术服务(上海)有限公司
小鼠 单克隆(LE-CD19)
  • 免疫组化-石蜡切片; 人类; 1:100; 图 4b
丹科医疗器械技术服务(上海)有限公司 CD19抗体(Dako, LE-CD19)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 4b). Nat Commun (2016) ncbi
小鼠 单克隆(LE-CD19)
  • 免疫组化-石蜡切片; 人类; 1:500; 图 2
丹科医疗器械技术服务(上海)有限公司 CD19抗体(Dako, LE-CD19)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:500 (图 2). J Immunol (2016) ncbi
赛信通(上海)生物试剂有限公司
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 2d
赛信通(上海)生物试剂有限公司 CD19抗体(Cell Signaling, 3574)被用于被用于免疫印迹在人类样本上 (图 2d). Mol Cell Biol (2018) ncbi
domestic rabbit 多克隆
  • 免疫细胞化学; 人类; 1:400; 图 1c
赛信通(上海)生物试剂有限公司 CD19抗体(Cell Signaling Technology, 3574)被用于被用于免疫细胞化学在人类样本上浓度为1:400 (图 1c). Oncogene (2016) ncbi
碧迪BD
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 1:100; 图 2c
碧迪BD CD19抗体(BD Horizon, 561121)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 2c). elife (2019) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 5e
碧迪BD CD19抗体(BD, HIB19)被用于被用于流式细胞仪在人类样本上 (图 5e). Nat Med (2019) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 图 s1
碧迪BD CD19抗体(BD Biosciences, SJ25C1)被用于被用于流式细胞仪在人类样本上 (图 s1). Front Immunol (2019) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 图 s3b
碧迪BD CD19抗体(BD Biosciences, 563036)被用于被用于流式细胞仪在人类样本上 (图 s3b). Nat Immunol (2018) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 图 s1a
碧迪BD CD19抗体(BD, 563325)被用于被用于流式细胞仪在人类样本上 (图 s1a). J Clin Invest (2018) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 小鼠; 图 s2a
碧迪BD CD19抗体(BD Biosciences, HIB19)被用于被用于流式细胞仪在小鼠样本上 (图 s2a). Eur J Immunol (2018) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 s7b
碧迪BD CD19抗体(BD, 555412)被用于被用于流式细胞仪在人类样本上 (图 s7b). Eur J Immunol (2018) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 3a
碧迪BD CD19抗体(BD Biosciences, 560994)被用于被用于流式细胞仪在人类样本上 (图 3a). Stem Cell Reports (2018) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 图 s5
碧迪BD CD19抗体(BD Biosciences, SJ25C1)被用于被用于流式细胞仪在人类样本上 (图 s5). J Clin Invest (2018) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 图 1b
碧迪BD CD19抗体(BD Bioscience, 557835)被用于被用于流式细胞仪在人类样本上 (图 1b). J Clin Invest (2018) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 s4a
碧迪BD CD19抗体(BD, HIB19)被用于被用于流式细胞仪在人类样本上 (图 s4a). J Clin Invest (2018) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 2a
碧迪BD CD19抗体(BD Biosciences, 555412)被用于被用于流式细胞仪在人类样本上 (图 2a). J Virol (2018) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 图 s1
碧迪BD CD19抗体(BD Biosciences, 557791)被用于被用于流式细胞仪在人类样本上 (图 s1). Front Immunol (2018) ncbi
小鼠 单克隆(HIB19)
  • 免疫组化-石蜡切片; 人类; 图 1b
碧迪BD CD19抗体(BD Biosciences, 555409)被用于被用于免疫组化-石蜡切片在人类样本上 (图 1b). Front Immunol (2018) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 小鼠; 图 1i
碧迪BD CD19抗体(BD Biosciences, 555413)被用于被用于流式细胞仪在小鼠样本上 (图 1i). Cell (2018) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 2a
碧迪BD CD19抗体(BD Biosciences, HIB19)被用于被用于流式细胞仪在人类样本上 (图 2a). Cancer Immunol Res (2018) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 小鼠; 图 4a
碧迪BD CD19抗体(BD Biosciences, SJ25C1)被用于被用于流式细胞仪在小鼠样本上 (图 4a). Mucosal Immunol (2018) ncbi
小鼠 单克隆(4G7)
  • 流式细胞仪; 人类; 图 1d
碧迪BD CD19抗体(BD Biosciences, 4G7)被用于被用于流式细胞仪在人类样本上 (图 1d). Nature (2018) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 st1
碧迪BD CD19抗体(BD, 560728)被用于被用于流式细胞仪在人类样本上 (图 st1). J Exp Med (2018) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 s7f
碧迪BD CD19抗体(BD Biosciences, 555415)被用于被用于流式细胞仪在人类样本上 (图 s7f). Cell (2018) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 4a
碧迪BD CD19抗体(BD Biosciences, HIB19)被用于被用于流式细胞仪在人类样本上 (图 4a). J Immunol (2018) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 图 2b
碧迪BD CD19抗体(BD, SJ25C1)被用于被用于流式细胞仪在人类样本上 (图 2b). Nat Med (2018) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 图 3a
碧迪BD CD19抗体(BD, SJ25C1)被用于被用于流式细胞仪在人类样本上 (图 3a). J Virol (2018) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD19抗体(BD Biosciences, HIB19)被用于被用于流式细胞仪在人类样本上 (图 1a). Front Immunol (2017) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 小鼠; 图 3b
碧迪BD CD19抗体(BD Biosciences, 555413)被用于被用于流式细胞仪在小鼠样本上 (图 3b). Cell Stem Cell (2017) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 1:10; 图 s2
碧迪BD CD19抗体(BD, HIB19)被用于被用于流式细胞仪在人类样本上浓度为1:10 (图 s2). Nat Commun (2017) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 1:200; 图 2a
碧迪BD CD19抗体(BD Biosciences, 560177)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 2a). PLoS ONE (2017) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 1:100; 图 4a
碧迪BD CD19抗体(BD Biosciences, HIB19)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 4a). Front Immunol (2017) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD Bioscience, SJ25C1)被用于被用于流式细胞仪在人类样本上. Nature (2017) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 1c
碧迪BD CD19抗体(BD, HIB19)被用于被用于流式细胞仪在人类样本上 (图 1c). Nature (2017) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 st1
碧迪BD CD19抗体(BD, HIB19)被用于被用于流式细胞仪在人类样本上 (图 st1). J Exp Med (2017) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 图 3g
碧迪BD CD19抗体(BD Biosciences, SJ25C1)被用于被用于流式细胞仪在人类样本上 (图 3g). Science (2017) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD Biosciences, HIB19)被用于被用于流式细胞仪在人类样本上. MBio (2017) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 图 1b
碧迪BD CD19抗体(BD Pharmingen, 340721)被用于被用于流式细胞仪在人类样本上 (图 1b). Scand J Immunol (2017) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 s2
碧迪BD CD19抗体(BD Pharmingen, 555415)被用于被用于流式细胞仪在人类样本上 (图 s2). Scand J Immunol (2017) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 1d
碧迪BD CD19抗体(BD Pharmingen, HIB19)被用于被用于流式细胞仪在人类样本上 (图 1d). J Clin Invest (2017) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD19抗体(BD Bioscience, 562441)被用于被用于流式细胞仪在人类样本上 (图 1a). F1000Res (2016) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 图 5c
碧迪BD CD19抗体(BD, 557835)被用于被用于流式细胞仪在人类样本上 (图 5c). Blood (2017) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 图 6b
碧迪BD CD19抗体(BD Biosciences, 340364)被用于被用于流式细胞仪在人类样本上 (图 6b). Mol Ther Methods Clin Dev (2017) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 6a
碧迪BD CD19抗体(BD Biosciences, 555413)被用于被用于流式细胞仪在人类样本上 (图 6a). Mol Ther Methods Clin Dev (2017) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 小鼠; 图 s4
碧迪BD CD19抗体(BD Biosciences, 340951)被用于被用于流式细胞仪在小鼠样本上 (图 s4). Nat Commun (2017) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 s2c
碧迪BD CD19抗体(BD, 555413)被用于被用于流式细胞仪在人类样本上 (图 s2c). Cell (2017) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 S1a
碧迪BD CD19抗体(BD, 555412)被用于被用于流式细胞仪在人类样本上 (图 S1a). Sci Rep (2017) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 6
碧迪BD CD19抗体(BD Biosciences, 555412)被用于被用于流式细胞仪在人类样本上 (图 6). Sci Rep (2017) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(Pharmingen, SJ25C1)被用于被用于流式细胞仪在人类样本上. Oncol Lett (2017) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD Bioscience, HIB19)被用于被用于流式细胞仪在人类样本上. Sci Rep (2017) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD Bioscience, SJ25C1)被用于被用于流式细胞仪在人类样本上. Sci Rep (2017) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 4a
碧迪BD CD19抗体(BD Bioscience, 562441)被用于被用于流式细胞仪在人类样本上 (图 4a). Sci Rep (2017) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 图 2c
碧迪BD CD19抗体(BD Biosciences, SJ25C1)被用于被用于流式细胞仪在人类样本上 (图 2c). Proc Natl Acad Sci U S A (2017) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD Biosciences, HIB19)被用于被用于流式细胞仪在人类样本上. J Immunol Res (2016) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 图 4b
碧迪BD CD19抗体(BD Biosciences, 557791)被用于被用于流式细胞仪在人类样本上 (图 4b). PLoS ONE (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 1:25; 图 1b
碧迪BD CD19抗体(BD Biosciences, HIB19)被用于被用于流式细胞仪在人类样本上浓度为1:25 (图 1b). Cell Transplant (2017) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 图 2c
碧迪BD CD19抗体(BD Biosciences, SJ25C1)被用于被用于流式细胞仪在人类样本上 (图 2c). Proc Natl Acad Sci U S A (2016) ncbi
小鼠 单克隆(4G7)
  • 流式细胞仪; 人类; 1:100; 图 s1c
碧迪BD CD19抗体(BD, 349209)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 s1c). Nature (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 s12a
碧迪BD CD19抗体(BD Biosciences, HIB19)被用于被用于流式细胞仪在人类样本上 (图 s12a). J Clin Invest (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 e6b
碧迪BD CD19抗体(BD Biosciences, HIB19)被用于被用于流式细胞仪在人类样本上 (图 e6b). Nature (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 表 3
碧迪BD CD19抗体(Becton Dickinson, HIB19)被用于被用于流式细胞仪在人类样本上 (表 3). N Biotechnol (2017) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD Biosciences, HIB19)被用于被用于流式细胞仪在人类样本上. J Virol (2017) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD Biosciences, HIB19)被用于被用于流式细胞仪在人类样本上. Mucosal Immunol (2017) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 图 1a, s2e
碧迪BD CD19抗体(BD Biosciences, 557835)被用于被用于流式细胞仪在人类样本上 (图 1a, s2e). JCI Insight (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 1a, s2e
碧迪BD CD19抗体(BD Biosciences, 555415)被用于被用于流式细胞仪在人类样本上 (图 1a, s2e). JCI Insight (2016) ncbi
小鼠 单克隆(4G7)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD Biosciences, 345776)被用于被用于流式细胞仪在人类样本上. Oncotarget (2016) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 图 st1
碧迪BD CD19抗体(BD Biosciences, 641395)被用于被用于流式细胞仪在人类样本上 (图 st1). PLoS ONE (2016) ncbi
小鼠 单克隆(4G7)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD, 4G7)被用于被用于流式细胞仪在人类样本上. J Exp Med (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 3
碧迪BD CD19抗体(BD PharMingen, 561742)被用于被用于流式细胞仪在人类样本上 (图 3). Stem Cell Reports (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 3d
碧迪BD CD19抗体(BD Biosciences, 555415)被用于被用于流式细胞仪在人类样本上 (图 3d). Nanomedicine (Lond) (2016) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 图 1
碧迪BD CD19抗体(BD Bioscience, SJ25C1)被用于被用于流式细胞仪在人类样本上 (图 1). J Interferon Cytokine Res (2016) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD19抗体(BD, SJ25C1)被用于被用于流式细胞仪在人类样本上 (图 1a). AIDS Res Hum Retroviruses (2016) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 图 s1b
碧迪BD CD19抗体(BD Biosciences, SJ25C1)被用于被用于流式细胞仪在人类样本上 (图 s1b). Sci Rep (2016) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 图 1
碧迪BD CD19抗体(BD Biosciences, 340719)被用于被用于流式细胞仪在人类样本上 (图 1). Mol Med Rep (2016) ncbi
小鼠 单克隆(4G7)
  • 流式细胞仪; 人类; 1:16; 图 s1c
碧迪BD CD19抗体(BD, 345776)被用于被用于流式细胞仪在人类样本上浓度为1:16 (图 s1c). Nat Biotechnol (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD19抗体(Becton Dickinson, HIB19)被用于被用于流式细胞仪在人类样本上 (图 1a). PLoS ONE (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD Biosciences, HIB19)被用于被用于流式细胞仪在人类样本上. Biomaterials (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 1:100; 表 s2
碧迪BD CD19抗体(BD, HIB19)被用于被用于流式细胞仪在人类样本上浓度为1:100 (表 s2). Nat Immunol (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD19抗体(BD Pharmingen, HIB19)被用于被用于流式细胞仪在人类样本上 (图 1a). J Allergy Clin Immunol (2016) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD19抗体(BD Biosciences, SJ25C1)被用于被用于流式细胞仪在人类样本上 (图 1a). Cytometry B Clin Cytom (2018) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD Pharmingen, HIB19)被用于被用于流式细胞仪在人类样本上. Clin Cancer Res (2017) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 图 4a
碧迪BD CD19抗体(BD, SJ25C1)被用于被用于流式细胞仪在人类样本上 (图 4a). J Immunol (2016) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 图 3
碧迪BD CD19抗体(BD, 339190)被用于被用于流式细胞仪在人类样本上 (图 3). PLoS Pathog (2016) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 图 2a
碧迪BD CD19抗体(BD Biosciences, SJ25C1)被用于被用于流式细胞仪在人类样本上 (图 2a). Clin Transl Gastroenterol (2016) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD19抗体(BD, SJ25C1)被用于被用于流式细胞仪在人类样本上 (图 1a). PLoS ONE (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD Biosciences, 561121)被用于被用于流式细胞仪在人类样本上. Nat Immunol (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 3d
碧迪BD CD19抗体(BD, HIB19)被用于被用于流式细胞仪在人类样本上 (图 3d). Angiogenesis (2016) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 图 3b
碧迪BD CD19抗体(BD Pharmingen, SJ25C1)被用于被用于流式细胞仪在人类样本上 (图 3b). J Clin Invest (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 1:25; 图 1b
碧迪BD CD19抗体(BD, HIB19)被用于被用于流式细胞仪在人类样本上浓度为1:25 (图 1b). Nat Med (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 1:200; 图 7f
碧迪BD CD19抗体(BD Biosciences, HIB19)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 7f). Nat Commun (2016) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 图 2
碧迪BD CD19抗体(BD Biosciences, SJ25C1)被用于被用于流式细胞仪在人类样本上 (图 2). Methods Mol Biol (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 s2a
碧迪BD CD19抗体(BD Biosciences, HIB19)被用于被用于流式细胞仪在人类样本上 (图 s2a). PLoS ONE (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 2
碧迪BD CD19抗体(BD, HIB-19)被用于被用于流式细胞仪在人类样本上 (图 2). JCI Insight (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 1:80; 图 3
碧迪BD CD19抗体(BD PharMingen, 561121)被用于被用于流式细胞仪在人类样本上浓度为1:80 (图 3). Oncoimmunology (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 小鼠
碧迪BD CD19抗体(BD Biosciences, HIB19)被用于被用于流式细胞仪在小鼠样本上. Nature (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 s3
碧迪BD CD19抗体(BD Biosciences, HIB19)被用于被用于流式细胞仪在人类样本上 (图 s3). PLoS ONE (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 1e
碧迪BD CD19抗体(BD, HIB19)被用于被用于流式细胞仪在人类样本上 (图 1e). Cancer Med (2016) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 图 s2
碧迪BD CD19抗体(BD Biosciences, SJ25C1)被用于被用于流式细胞仪在人类样本上 (图 s2). Eur J Immunol (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 s4
碧迪BD CD19抗体(BD Biosciences, HIB19)被用于被用于流式细胞仪在人类样本上 (图 s4). Oncotarget (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 s1b
碧迪BD CD19抗体(BD Biosciences, HIB19)被用于被用于流式细胞仪在人类样本上 (图 s1b). Science (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 st1
碧迪BD CD19抗体(BD, 555413)被用于被用于流式细胞仪在人类样本上 (图 st1). Exp Cell Res (2016) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 图 1b
碧迪BD CD19抗体(BD Biosciences, 557791)被用于被用于流式细胞仪在人类样本上 (图 1b). Haematologica (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD, HIB19)被用于被用于流式细胞仪在人类样本上. Nature (2016) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 图 6a
碧迪BD CD19抗体(Becton Dickinson, 560911)被用于被用于流式细胞仪在人类样本上 (图 6a). BMC Biotechnol (2016) ncbi
小鼠 单克隆(HIB19)
  • 其他; 人类; 图 st1
碧迪BD CD19抗体(BD, HIB19)被用于被用于其他在人类样本上 (图 st1). Mol Cell Proteomics (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 表 2
碧迪BD CD19抗体(BD, HIB19)被用于被用于流式细胞仪在人类样本上 (表 2). Cytometry B Clin Cytom (2017) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 2e
碧迪BD CD19抗体(BD Biosciences, HIB19)被用于被用于流式细胞仪在人类样本上 (图 2e). Nat Genet (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 1
碧迪BD CD19抗体(BD Biosciences, 555413)被用于被用于流式细胞仪在人类样本上 (图 1). Sci Rep (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 4b
碧迪BD CD19抗体(BD, 555413)被用于被用于流式细胞仪在人类样本上 (图 4b). Front Immunol (2015) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 表 1
碧迪BD CD19抗体(Becton Dickinson, SJ25C1)被用于被用于流式细胞仪在人类样本上 (表 1). J Transl Med (2015) ncbi
小鼠 单克隆(4G7)
  • 流式细胞仪; 人类; 图 4a
碧迪BD CD19抗体(BD, 349209)被用于被用于流式细胞仪在人类样本上 (图 4a). Science (2016) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 图 s1a, 4a, s1c
碧迪BD CD19抗体(BD, 340364)被用于被用于流式细胞仪在人类样本上 (图 s1a, 4a, s1c). Science (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 3a
碧迪BD CD19抗体(BD Pharmingen, 555415)被用于被用于流式细胞仪在人类样本上 (图 3a). J Immunol (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 2
碧迪BD CD19抗体(BD Biosciences, 561295)被用于被用于流式细胞仪在人类样本上 (图 2). MAbs (2016) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD, SJ25C1)被用于被用于流式细胞仪在人类样本上. Am J Transplant (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 s1b
碧迪BD CD19抗体(BD Biosciences, HIB19)被用于被用于流式细胞仪在人类样本上 (图 s1b). J Immunol (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 1
碧迪BD CD19抗体(BD Biosciences, 555415)被用于被用于流式细胞仪在人类样本上 (图 1). Oncoimmunology (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 s4
碧迪BD CD19抗体(BD Biosciences, 555411)被用于被用于流式细胞仪在人类样本上 (图 s4). Nature (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 3b
碧迪BD CD19抗体(BD PharMingen, HIB19)被用于被用于流式细胞仪在人类样本上 (图 3b). Hum Vaccin Immunother (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 3a
碧迪BD CD19抗体(BD Biosciences, HIB19)被用于被用于流式细胞仪在人类样本上 (图 3a). PLoS Negl Trop Dis (2015) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD Biosciences, 340437)被用于被用于流式细胞仪在人类样本上. Leukemia (2016) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD, HIB19)被用于被用于流式细胞仪在人类样本上. J Immunol Res (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD19抗体(BD Biosciences, HIB19)被用于被用于流式细胞仪在人类样本上 (图 1a). Arthritis Res Ther (2015) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 图 4a
碧迪BD CD19抗体(BD Biosciences, 557835)被用于被用于流式细胞仪在人类样本上 (图 4a). Mol Ther Methods Clin Dev (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 1
碧迪BD CD19抗体(BD Bioscience, 555413)被用于被用于流式细胞仪在人类样本上 (图 1). J Hematol Oncol (2015) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 图 2a
碧迪BD CD19抗体(BD Biosciences, SJ25C1)被用于被用于流式细胞仪在人类样本上 (图 2a). Ann Rheum Dis (2016) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD, 340951)被用于被用于流式细胞仪在人类样本上. J Exp Med (2015) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 图 5
碧迪BD CD19抗体(BD Pharmingen, SJ25C1)被用于被用于流式细胞仪在人类样本上 (图 5). Nat Immunol (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 1:100; 图 s10a
碧迪BD CD19抗体(Becton Dickinson, HIB19)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 s10a). Nat Med (2015) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 1:100; 图 s3
碧迪BD CD19抗体(BD, 560177)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 s3). Nat Commun (2015) ncbi
小鼠 单克隆(4G7)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(Becton-Dickinson, 4G7)被用于被用于流式细胞仪在人类样本上. Histochem Cell Biol (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD Pharmingen, #555415)被用于被用于流式细胞仪在人类样本上. Immunol Invest (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD Biosciences, HIB19)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2015) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 表 4
碧迪BD CD19抗体(BD Bioscience, Sj25C1)被用于被用于流式细胞仪在人类样本上 (表 4). Cytometry B Clin Cytom (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD, 555412)被用于被用于流式细胞仪在人类样本上. Scand J Immunol (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD Pharmingen, 555415)被用于被用于流式细胞仪在人类样本上. Arthritis Res Ther (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD Biosciences, 555413)被用于被用于流式细胞仪在人类样本上. Cancer Immunol Immunother (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD, HIB19)被用于被用于流式细胞仪在人类样本上. Nature (2015) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD, SJ25C1)被用于被用于流式细胞仪在人类样本上. J Allergy Clin Immunol (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 1e
碧迪BD CD19抗体(BD Biosciences, HIB19)被用于被用于流式细胞仪在人类样本上 (图 1e). J Immunol (2015) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 图 1
碧迪BD CD19抗体(BD Biosciences, SJ25C1)被用于被用于流式细胞仪在人类样本上 (图 1). Int Immunol (2015) ncbi
小鼠 单克隆(4G7)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(Becton Dickinson, 349209)被用于被用于流式细胞仪在人类样本上. Curr Protoc Pharmacol (2015) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD Biosciences, SJ25C1)被用于被用于流式细胞仪在人类样本上. PLoS Med (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 1
碧迪BD CD19抗体(BD Biosciences, HIB19)被用于被用于流式细胞仪在人类样本上 (图 1). J Immunol (2015) ncbi
小鼠 单克隆(4G7)
  • 流式细胞仪; 人类; 表 2
碧迪BD CD19抗体(BD Bioscience, 4G7)被用于被用于流式细胞仪在人类样本上 (表 2). Clin Transplant (2015) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD Pharmingen, SJ25C1)被用于被用于流式细胞仪在人类样本上. Clin Cancer Res (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD Pharmingen, 555412)被用于被用于流式细胞仪在人类样本上. Alcohol (2015) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(Becton Dickinson, SJ25C1)被用于被用于流式细胞仪在人类样本上. J Leukoc Biol (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD, 560353)被用于被用于流式细胞仪在人类样本上. Cytometry A (2015) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 1:100
碧迪BD CD19抗体(BD, 557835)被用于被用于流式细胞仪在人类样本上浓度为1:100. Cytometry A (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD Biosciences, HIB19)被用于被用于流式细胞仪在人类样本上. Arthritis Rheumatol (2015) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD, SJ25C1)被用于被用于流式细胞仪在人类样本上. Eur J Cancer (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 5
碧迪BD CD19抗体(Becton Dickinson, 555413)被用于被用于流式细胞仪在人类样本上 (图 5). Neuromuscul Disord (2015) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD, SJ25C1)被用于被用于流式细胞仪在人类样本上. Cytometry B Clin Cytom (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 2
碧迪BD CD19抗体(BD Biosciences, 557921)被用于被用于流式细胞仪在人类样本上 (图 2). PLoS ONE (2014) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 1
碧迪BD CD19抗体(BD Biosciences, HIB19)被用于被用于流式细胞仪在人类样本上 (图 1). J Leukoc Biol (2015) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD PharMingen, SJ25C1)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(4G7)
  • 流式细胞仪; 人类; 图 s3
碧迪BD CD19抗体(Becton Dickinson, 4G7)被用于被用于流式细胞仪在人类样本上 (图 s3). Blood (2015) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD Biosciences, HIB19)被用于被用于流式细胞仪在人类样本上. J Immunol (2014) ncbi
小鼠 单克隆(HIB19)
  • 免疫细胞化学; 人类
碧迪BD CD19抗体(BD Biosciences, HIB19)被用于被用于免疫细胞化学在人类样本上. J Immunol (2014) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 5 ul per test
碧迪BD CD19抗体(BD Biosciences, SJ25C1)被用于被用于流式细胞仪在人类样本上浓度为5 ul per test. Cytometry B Clin Cytom (2014) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD, SJ25C1)被用于被用于流式细胞仪在人类样本上. J Exp Med (2014) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD Biosciences, HIB19)被用于被用于流式细胞仪在人类样本上. Proc Natl Acad Sci U S A (2014) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 1
碧迪BD CD19抗体(BD, HIB19)被用于被用于流式细胞仪在人类样本上 (图 1). J Exp Med (2014) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 s1
碧迪BD CD19抗体(BD Bioscience, HIB19)被用于被用于流式细胞仪在人类样本上 (图 s1). J Immunol (2014) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD Biosciences, HIB19)被用于被用于流式细胞仪在人类样本上. Am J Transplant (2014) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 4a
碧迪BD CD19抗体(BD Biosciences, HIB19)被用于被用于流式细胞仪在人类样本上 (图 4a). Biol Blood Marrow Transplant (2014) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD Biosciences, SJ25C1)被用于被用于流式细胞仪在人类样本上. Immunol Invest (2014) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 1:100
碧迪BD CD19抗体(BD Biosciences, 555413)被用于被用于流式细胞仪在人类样本上浓度为1:100. J Immunol (2014) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD Bioscience, SJ25C1)被用于被用于流式细胞仪在人类样本上. Blood (2014) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD Bioscience, HIB19)被用于被用于流式细胞仪在人类样本上. Blood (2014) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD Biosciences, SJ25C1)被用于被用于流式细胞仪在人类样本上. J Clin Immunol (2014) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD Bioscience, HIB19)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(Becton Dickinson, SJ25C1)被用于被用于流式细胞仪在人类样本上. Biomed Res Int (2014) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD Bioscience, 555415)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 图 s5
碧迪BD CD19抗体(BD Biosciences, 555412)被用于被用于流式细胞仪在人类样本上 (图 s5). PLoS Pathog (2014) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD19抗体(Becton Dickinson, SJ25C1)被用于被用于流式细胞仪在人类样本上 (图 1a). Clin Immunol (2014) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD Biosciences, SJ25C1)被用于被用于流式细胞仪在人类样本上. Immunology (2014) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 图 1
碧迪BD CD19抗体(BD Biosciences, SJ25C1)被用于被用于流式细胞仪在人类样本上 (图 1). Cytometry B Clin Cytom (2014) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD Biosciences, SJ25C1)被用于被用于流式细胞仪在人类样本上. J Allergy Clin Immunol (2014) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD, 561031)被用于被用于流式细胞仪在人类样本上. Part Part Syst Charact (2013) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类; 1:100
  • 流式细胞仪; 小鼠; 1:100
碧迪BD CD19抗体(BD Biosciences, 555412)被用于被用于流式细胞仪在人类样本上浓度为1:100 和 被用于流式细胞仪在小鼠样本上浓度为1:100. Nat Med (2013) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类; 表 1
碧迪BD CD19抗体(BD, clone SJ25C1)被用于被用于流式细胞仪在人类样本上 (表 1). Cytopathology (2014) ncbi
小鼠 单克隆(HIB19)
  • 酶联免疫吸附测定; 人类
碧迪BD CD19抗体(BD Biosciences, HIB19)被用于被用于酶联免疫吸附测定在人类样本上. J Transl Med (2013) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD, 561295)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2012) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD, 560177)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2012) ncbi
小鼠 单克隆(SJ25C1)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD, clone SJ25C1)被用于被用于流式细胞仪在人类样本上. J Immunol Methods (2009) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD, HIB19)被用于被用于流式细胞仪在人类样本上. Blood (2008) ncbi
小鼠 单克隆(HIB19)
  • 流式细胞仪; 人类
碧迪BD CD19抗体(BD PharMingen, HIB19)被用于被用于流式细胞仪在人类样本上. Cytometry B Clin Cytom (2006) ncbi
默克密理博中国
小鼠 单克隆(FMC63)
  • 免疫细胞化学; 人类; 1:500
默克密理博中国 CD19抗体(Millipore, FMC63)被用于被用于免疫细胞化学在人类样本上浓度为1:500. J Assist Reprod Genet (2014) ncbi
小鼠 单克隆(FMC63)
  • 酶联免疫吸附测定; 人类
默克密理博中国 CD19抗体(Millipore, FMC63)被用于被用于酶联免疫吸附测定在人类样本上. J Transl Med (2013) ncbi
小鼠 单克隆(FMC63)
  • 免疫细胞化学; 人类; 1:200
默克密理博中国 CD19抗体(Millipore, FMC63)被用于被用于免疫细胞化学在人类样本上浓度为1:200. Cell Transplant (2013) ncbi
文章列表
  1. Gate D, Saligrama N, Leventhal O, Yang A, Unger M, Middeldorp J, et al. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer's disease. Nature. 2020;577:399-404 pubmed 出版商
  2. Ladinsky M, Khamaikawin W, Jung Y, Lin S, Lam J, An D, et al. Mechanisms of virus dissemination in bone marrow of HIV-1-infected humanized BLT mice. elife. 2019;8: pubmed 出版商
  3. Pecher A, Kettemann F, Asteriti E, Schmid H, Duerr Stoerzer S, Keppeler H, et al. Invariant natural killer T cells are functionally impaired in patients with systemic sclerosis. Arthritis Res Ther. 2019;21:212 pubmed 出版商
  4. Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck W, et al. Comprehensive Integration of Single-Cell Data. Cell. 2019;: pubmed 出版商
  5. Ingegnere T, Mariotti F, Pelosi A, Quintarelli C, De Angelis B, Tumino N, et al. Human CAR NK Cells: A New Non-viral Method Allowing High Efficient Transfection and Strong Tumor Cell Killing. Front Immunol. 2019;10:957 pubmed 出版商
  6. Davis C, Jackson K, McElroy A, Halfmann P, Huang J, Chennareddy C, et al. Longitudinal Analysis of the Human B Cell Response to Ebola Virus Infection. Cell. 2019;: pubmed 出版商
  7. Zumaquero E, Stone S, Scharer C, Jenks S, Nellore A, Mousseau B, et al. IFNγ induces epigenetic programming of human T-bethi B cells and promotes TLR7/8 and IL-21 induced differentiation. elife. 2019;8: pubmed 出版商
  8. Rühl J, Citterio C, Engelmann C, Haigh T, Dzionek A, Dreyer J, et al. Heterologous prime-boost vaccination protects against EBV antigen-expressing lymphomas. J Clin Invest. 2019;129:2071-2087 pubmed 出版商
  9. Pavel Dinu M, Wiebking V, Dejene B, Srifa W, Mantri S, Nicolas C, et al. Gene correction for SCID-X1 in long-term hematopoietic stem cells. Nat Commun. 2019;10:1634 pubmed 出版商
  10. Hammerich L, Marron T, Upadhyay R, Svensson Arvelund J, Dhainaut M, Hussein S, et al. Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination. Nat Med. 2019;25:814-824 pubmed 出版商
  11. Sweere J, Van Belleghem J, Ishak H, Bach M, Popescu M, Sunkari V, et al. Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection. Science. 2019;363: pubmed 出版商
  12. Crippa S, Rossella V, Aprile A, Silvestri L, Rivis S, Scaramuzza S, et al. Bone marrow stromal cells from β-thalassemia patients have impaired hematopoietic supportive capacity. J Clin Invest. 2019;129:1566-1580 pubmed 出版商
  13. Dosch M, Zindel J, Jebbawi F, Melin N, Sánchez Taltavull D, Stroka D, et al. Connexin-43-dependent ATP release mediates macrophage activation during sepsis. elife. 2019;8: pubmed 出版商
  14. Boscheinen J, Thomann S, Knipe D, Deluca N, Schuler Thurner B, Gross S, et al. Generation of an Oncolytic Herpes Simplex Virus 1 Expressing Human MelanA. Front Immunol. 2019;10:2 pubmed 出版商
  15. Franco L, Gadkari M, Howe K, Sun J, Kardava L, Kumar P, et al. Immune regulation by glucocorticoids can be linked to cell type-dependent transcriptional responses. J Exp Med. 2019;216:384-406 pubmed 出版商
  16. Schlenner S, Pasciuto E, Lagou V, Burton O, Prezzemolo T, Junius S, et al. NFIL3 mutations alter immune homeostasis and sensitise for arthritis pathology. Ann Rheum Dis. 2019;78:342-349 pubmed 出版商
  17. Tan H, Jegaskanda S, Juno J, Esterbauer R, Wong J, Kelly H, et al. Subdominance and poor intrinsic immunogenicity limit humoral immunity targeting influenza HA stem. J Clin Invest. 2019;129:850-862 pubmed 出版商
  18. Wiedemann G, Aithal C, Kraechan A, Heise C, Cadilha B, Zhang J, et al. Microphthalmia-Associated Transcription Factor (MITF) Regulates Immune Cell Migration into Melanoma. Transl Oncol. 2019;12:350-360 pubmed 出版商
  19. Kelly A, Günaltay S, McEntee C, Shuttleworth E, Smedley C, Houston S, et al. Human monocytes and macrophages regulate immune tolerance via integrin αvβ8-mediated TGFβ activation. J Exp Med. 2018;215:2725-2736 pubmed 出版商
  20. Bradley T, Peppa D, Pedroza Pacheco I, Li D, Cain D, Henao R, et al. RAB11FIP5 Expression and Altered Natural Killer Cell Function Are Associated with Induction of HIV Broadly Neutralizing Antibody Responses. Cell. 2018;175:387-399.e17 pubmed 出版商
  21. Al Maskari M, Care M, Robinson E, Cocco M, Tooze R, Doody G. Site-1 protease function is essential for the generation of antibody secreting cells and reprogramming for secretory activity. Sci Rep. 2018;8:14338 pubmed 出版商
  22. Mangolini M, Götte F, Moore A, Ammon T, Oelsner M, Lutzny Geier G, et al. Notch2 controls non-autonomous Wnt-signalling in chronic lymphocytic leukaemia. Nat Commun. 2018;9:3839 pubmed 出版商
  23. Kong X, Martinez Barricarte R, Kennedy J, Mele F, Lazarov T, Deenick E, et al. Disruption of an antimycobacterial circuit between dendritic and helper T cells in human SPPL2a deficiency. Nat Immunol. 2018;19:973-985 pubmed 出版商
  24. Bagashev A, Sotillo E, Tang C, Black K, Perazzelli J, Seeholzer S, et al. CD19 Alterations Emerging after CD19-Directed Immunotherapy Cause Retention of the Misfolded Protein in the Endoplasmic Reticulum. Mol Cell Biol. 2018;38: pubmed 出版商
  25. Young M, Mitchell T, Vieira Braga F, Tran M, Stewart B, Ferdinand J, et al. Single-cell transcriptomes from human kidneys reveal the cellular identity of renal tumors. Science. 2018;361:594-599 pubmed 出版商
  26. Burton A, Pallett L, McCoy L, Suveizdyte K, Amin O, Swadling L, et al. Circulating and intrahepatic antiviral B cells are defective in hepatitis B. J Clin Invest. 2018;128:4588-4603 pubmed 出版商
  27. Imbrechts M, De Samblancx K, Fierens K, Brisse E, Vandenhaute J, Mitera T, et al. IFN-γ stimulates CpG-induced IL-10 production in B cells via p38 and JNK signalling pathways. Eur J Immunol. 2018;48:1506-1521 pubmed 出版商
  28. Voigt J, Malone D, Dias J, Leeansyah E, Björkström N, Ljunggren H, et al. Proteome analysis of human CD56neg NK cells reveals a homogeneous phenotype surprisingly similar to CD56dim NK cells. Eur J Immunol. 2018;48:1456-1469 pubmed 出版商
  29. Yang X, Zhou J, He J, Liu J, Wang H, Liu Y, et al. An Immune System-Modified Rat Model for Human Stem Cell Transplantation Research. Stem Cell Reports. 2018;11:514-521 pubmed 出版商
  30. Moysi E, Pallikkuth S, de Armas L, Gonzalez L, Ambrozak D, George V, et al. Altered immune cell follicular dynamics in HIV infection following influenza vaccination. J Clin Invest. 2018;128:3171-3185 pubmed 出版商
  31. Boutboul D, Kuehn H, Van de Wyngaert Z, Niemela J, Callebaut I, Stoddard J, et al. Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiency. J Clin Invest. 2018;128:3071-3087 pubmed 出版商
  32. Honeycutt J, Liao B, Nixon C, Cleary R, Thayer W, Birath S, et al. T cells establish and maintain CNS viral infection in HIV-infected humanized mice. J Clin Invest. 2018;128:2862-2876 pubmed 出版商
  33. Morrissey M, Williamson A, Steinbach A, Roberts E, Kern N, Headley M, et al. Chimeric antigen receptors that trigger phagocytosis. elife. 2018;7: pubmed 出版商
  34. Yeo L, Woodwyk A, Sood S, Lorenc A, Eichmann M, Pujol Autonell I, et al. Autoreactive T effector memory differentiation mirrors β cell function in type 1 diabetes. J Clin Invest. 2018;128:3460-3474 pubmed 出版商
  35. Kiener R, Fleischmann M, Wiegand M, Lemmermann N, Schwegler C, Kaufmann C, et al. Efficient Delivery of Human Cytomegalovirus T Cell Antigens by Attenuated Sendai Virus Vectors. J Virol. 2018;92: pubmed 出版商
  36. Risnes L, Christophersen A, Dahal Koirala S, Neumann R, Sandve G, Sarna V, et al. Disease-driving CD4+ T cell clonotypes persist for decades in celiac disease. J Clin Invest. 2018;128:2642-2650 pubmed 出版商
  37. Sullivan N, Reuter Monslow M, Sei J, Durr E, Davis C, Chang C, et al. Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in Humans. J Virol. 2018;92: pubmed 出版商
  38. Roders N, Herr F, Ambroise G, Thaunat O, Portier A, Vazquez A, et al. SYK Inhibition Induces Apoptosis in Germinal Center-Like B Cells by Modulating the Antiapoptotic Protein Myeloid Cell Leukemia-1, Affecting B-Cell Activation and Antibody Production. Front Immunol. 2018;9:787 pubmed 出版商
  39. He X, Kläsener K, Iype J, Becker M, Maity P, Cavallari M, et al. Continuous signaling of CD79b and CD19 is required for the fitness of Burkitt lymphoma B cells. EMBO J. 2018;37: pubmed 出版商
  40. Panda S, Facchinetti V, Voynova E, Hanabuchi S, Karnell J, Hanna R, et al. Galectin-9 inhibits TLR7-mediated autoimmunity in murine lupus models. J Clin Invest. 2018;128:1873-1887 pubmed 出版商
  41. Liu J, Huang X, Hao S, Wang Y, Liu M, Xu J, et al. Peli1 negatively regulates noncanonical NF-κB signaling to restrain systemic lupus erythematosus. Nat Commun. 2018;9:1136 pubmed 出版商
  42. Xiao G, Chan L, Klemm L, Braas D, Chen Z, Geng H, et al. B-Cell-Specific Diversion of Glucose Carbon Utilization Reveals a Unique Vulnerability in B Cell Malignancies. Cell. 2018;173:470-484.e18 pubmed 出版商
  43. Vanshylla K, Bartsch C, Hitzing C, Krümpelmann L, Wienands J, Engels N. Grb2 and GRAP connect the B cell antigen receptor to Erk MAP kinase activation in human B cells. Sci Rep. 2018;8:4244 pubmed 出版商
  44. Oei V, Siernicka M, Graczyk Jarzynka A, Hoel H, Yang W, Palacios D, et al. Intrinsic Functional Potential of NK-Cell Subsets Constrains Retargeting Driven by Chimeric Antigen Receptors. Cancer Immunol Res. 2018;6:467-480 pubmed 出版商
  45. Trapecar M, Khan S, Cohn B, Wu F, Sanjabi S. B cells are the predominant mediators of early systemic viral dissemination during rectal LCMV infection. Mucosal Immunol. 2018;11:1158-1167 pubmed 出版商
  46. Han S, Yang S, Jo H, Oh Y, Park M, Kim J, et al. BAFF and APRIL expression as an autoimmune signature of membranous nephropathy. Oncotarget. 2018;9:3292-3302 pubmed 出版商
  47. Vo L, Kinney M, Liu X, Zhang Y, Barragan J, Sousa P, et al. Regulation of embryonic haematopoietic multipotency by EZH1. Nature. 2018;553:506-510 pubmed 出版商
  48. Tissino E, Benedetti D, Herman S, ten Hacken E, Ahn I, Chaffee K, et al. Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia. J Exp Med. 2018;215:681-697 pubmed 出版商
  49. Pugh J, Nemat Gorgani N, Norman P, Guethlein L, Parham P. Human NK Cells Downregulate Zap70 and Syk in Response to Prolonged Activation or DNA Damage. J Immunol. 2018;200:1146-1158 pubmed 出版商
  50. Wu X, Dao Thi V, Huang Y, Billerbeck E, Saha D, Hoffmann H, et al. Intrinsic Immunity Shapes Viral Resistance of Stem Cells. Cell. 2018;172:423-438.e25 pubmed 出版商
  51. Amodio D, Cotugno N, Macchiarulo G, Rocca S, Dimopoulos Y, Castrucci M, et al. Quantitative Multiplexed Imaging Analysis Reveals a Strong Association between Immunogen-Specific B Cell Responses and Tonsillar Germinal Center Immune Dynamics in Children after Influenza Vaccination. J Immunol. 2018;200:538-550 pubmed 出版商
  52. Krishnan B, Massilamany C, Basavalingappa R, Gangaplara A, Rajasekaran R, Afzal M, et al. Epitope Mapping of SERCA2a Identifies an Antigenic Determinant That Induces Mainly Atrial Myocarditis in A/J Mice. J Immunol. 2018;200:523-537 pubmed 出版商
  53. Fry T, Shah N, Orentas R, Stetler Stevenson M, Yuan C, Ramakrishna S, et al. CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy. Nat Med. 2018;24:20-28 pubmed 出版商
  54. Moreno Cubero E, Subira D, Sanz de Villalobos E, Parra Cid T, Madejon A, Miquel J, et al. According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1low HCV-Specific CD8+ Cell Reactivity. J Virol. 2018;92: pubmed 出版商
  55. Jeong J, Hong S, Kwon O, Ghang B, Hwang I, Kim Y, et al. CD14+ Cells with the Phenotype of Infiltrated Monocytes Consist of Distinct Populations Characterized by Anti-inflammatory as well as Pro-inflammatory Activity in Gouty Arthritis. Front Immunol. 2017;8:1260 pubmed 出版商
  56. Tothova Z, Krill Burger J, Popova K, Landers C, Sievers Q, Yudovich D, et al. Multiplex CRISPR/Cas9-Based Genome Editing in Human Hematopoietic Stem Cells Models Clonal Hematopoiesis and Myeloid Neoplasia. Cell Stem Cell. 2017;21:547-555.e8 pubmed 出版商
  57. Arthur Huang K, Chen M, Huang Y, Shih S, Chiu C, Lin J, et al. Epitope-associated and specificity-focused features of EV71-neutralizing antibody repertoires from plasmablasts of infected children. Nat Commun. 2017;8:762 pubmed 出版商
  58. Kyoizumi S, Kubo Y, Kajimura J, Yoshida K, Hayashi T, Nakachi K, et al. Fate Decision Between Group 3 Innate Lymphoid and Conventional NK Cell Lineages by Notch Signaling in Human Circulating Hematopoietic Progenitors. J Immunol. 2017;199:2777-2793 pubmed 出版商
  59. Salio M, Gasser O, González López C, Martens A, Veerapen N, Gileadi U, et al. Activation of Human Mucosal-Associated Invariant T Cells Induces CD40L-Dependent Maturation of Monocyte-Derived and Primary Dendritic Cells. J Immunol. 2017;199:2631-2638 pubmed 出版商
  60. Pinaud L, Samassa F, Porat Z, Ferrari M, Belotserkovsky I, Parsot C, et al. Injection of T3SS effectors not resulting in invasion is the main targeting mechanism of Shigella toward human lymphocytes. Proc Natl Acad Sci U S A. 2017;114:9954-9959 pubmed 出版商
  61. Svensson A, Patzi Churqui M, Schlüter K, Lind L, Eriksson K. Maturation-dependent expression of AIM2 in human B-cells. PLoS ONE. 2017;12:e0183268 pubmed 出版商
  62. Delso Vallejo M, Kollet J, Koehl U, Huppert V. Influence of Irradiated Peripheral Blood Mononuclear Cells on Both Ex Vivo Proliferation of Human Natural Killer Cells and Change in Cellular Property. Front Immunol. 2017;8:854 pubmed 出版商
  63. Lunemann S, Martrus G, Goebels H, Kautz T, Langeneckert A, Salzberger W, et al. Hobit expression by a subset of human liver-resident CD56bright Natural Killer cells. Sci Rep. 2017;7:6676 pubmed 出版商
  64. Jiang X, Björkström N, Melum E. Intact CD100-CD72 Interaction Necessary for TCR-Induced T Cell Proliferation. Front Immunol. 2017;8:765 pubmed 出版商
  65. Papa I, Saliba D, Ponzoni M, Bustamante S, Canete P, Gonzalez Figueroa P, et al. TFH-derived dopamine accelerates productive synapses in germinal centres. Nature. 2017;547:318-323 pubmed 出版商
  66. Ott P, Hu Z, Keskin D, Shukla S, Sun J, Bozym D, et al. An immunogenic personal neoantigen vaccine for patients with melanoma. Nature. 2017;547:217-221 pubmed 出版商
  67. Dulberger C, McMurtrey C, Hölzemer A, Neu K, Liu V, Steinbach A, et al. Human Leukocyte Antigen F Presents Peptides and Regulates Immunity through Interactions with NK Cell Receptors. Immunity. 2017;46:1018-1029.e7 pubmed 出版商
  68. Sugimura R, Jha D, Han A, Soria Valles C, da Rocha E, Lu Y, et al. Haematopoietic stem and progenitor cells from human pluripotent stem cells. Nature. 2017;545:432-438 pubmed 出版商
  69. Arumugakani G, Stephenson S, Newton D, Rawstron A, Emery P, Doody G, et al. Early Emergence of CD19-Negative Human Antibody-Secreting Cells at the Plasmablast to Plasma Cell Transition. J Immunol. 2017;198:4618-4628 pubmed 出版商
  70. Cerboni S, Jeremiah N, Gentili M, Gehrmann U, Conrad C, Stolzenberg M, et al. Intrinsic antiproliferative activity of the innate sensor STING in T lymphocytes. J Exp Med. 2017;214:1769-1785 pubmed 出版商
  71. See P, Dutertre C, Chen J, Günther P, McGovern N, Irac S, et al. Mapping the human DC lineage through the integration of high-dimensional techniques. Science. 2017;356: pubmed 出版商
  72. Pryke K, Abraham J, Sali T, Gall B, Archer I, Liu A, et al. A Novel Agonist of the TRIF Pathway Induces a Cellular State Refractory to Replication of Zika, Chikungunya, and Dengue Viruses. MBio. 2017;8: pubmed 出版商
  73. Pérez Martínez C, Maravillas Montero J, Meza Herrera I, Vences Catalan F, Zlotnik A, Santos Argumedo L. Tspan33 is Expressed in Transitional and Memory B Cells, but is not Responsible for High ADAM10 Expression. Scand J Immunol. 2017;86:23-30 pubmed 出版商
  74. Villani A, Satija R, Reynolds G, Sarkizova S, Shekhar K, Fletcher J, et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science. 2017;356: pubmed 出版商
  75. Cottineau J, Kottemann M, Lach F, Kang Y, Vély F, Deenick E, et al. Inherited GINS1 deficiency underlies growth retardation along with neutropenia and NK cell deficiency. J Clin Invest. 2017;127:1991-2006 pubmed 出版商
  76. Llibre A, Garner L, Partridge A, Freeman G, Klenerman P, Willberg C. Expression of lectin-like transcript-1 in human tissues. F1000Res. 2016;5:2929 pubmed 出版商
  77. Chen C, Sun W, Chen J, Huang J. Dynamic variations of the peripheral blood immune cell subpopulation in patients with critical H7N9 swine-origin influenza A virus infection: A retrospective small-scale study. Exp Ther Med. 2017;13:1490-1494 pubmed 出版商
  78. Johnson S, Dempsey C, Parker C, Mironov A, Bradley H, Saha V. Acute lymphoblastic leukaemia cells produce large extracellular vesicles containing organelles and an active cytoskeleton. J Extracell Vesicles. 2017;6:1294339 pubmed 出版商
  79. Pyöriä L, Toppinen M, Mäntylä E, Hedman L, Aaltonen L, Vihinen Ranta M, et al. Extinct type of human parvovirus B19 persists in tonsillar B cells. Nat Commun. 2017;8:14930 pubmed 出版商
  80. Cooper A, Lill G, Shaw K, Carbonaro Sarracino D, Davila A, Sokolic R, et al. Cytoreductive conditioning intensity predicts clonal diversity in ADA-SCID retroviral gene therapy patients. Blood. 2017;129:2624-2635 pubmed 出版商
  81. Dourado K, Baik J, Oliveira V, Beltrame M, Yamamoto A, Theuer C, et al. Endoglin: a novel target for therapeutic intervention in acute leukemias revealed in xenograft mouse models. Blood. 2017;129:2526-2536 pubmed 出版商
  82. Chang K, Smith S, Sullivan T, Chen K, Zhou Q, West J, et al. Long-Term Engraftment and Fetal Globin Induction upon BCL11A Gene Editing in Bone-Marrow-Derived CD34+ Hematopoietic Stem and Progenitor Cells. Mol Ther Methods Clin Dev. 2017;4:137-148 pubmed 出版商
  83. Amara K, Clay E, Yeo L, Ramsköld D, Spengler J, Sippl N, et al. B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis. J Autoimmun. 2017;81:34-43 pubmed 出版商
  84. van der Velden V, Flores Montero J, Perez Andres M, Martin Ayuso M, Crespo O, Blanco E, et al. Optimization and testing of dried antibody tube: The EuroFlow LST and PIDOT tubes as examples. J Immunol Methods. 2017;: pubmed 出版商
  85. Shahi P, Kim S, Haliburton J, Gartner Z, Abate A. Abseq: Ultrahigh-throughput single cell protein profiling with droplet microfluidic barcoding. Sci Rep. 2017;7:44447 pubmed 出版商
  86. Lopes F, Bálint Å, Valvo S, Felce J, Hessel E, Dustin M, et al. Membrane nanoclusters of FcγRI segregate from inhibitory SIRPα upon activation of human macrophages. J Cell Biol. 2017;216:1123-1141 pubmed 出版商
  87. Pardi N, Secreto A, Shan X, Debonera F, Glover J, Yi Y, et al. Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge. Nat Commun. 2017;8:14630 pubmed 出版商
  88. Israel L, Wang Y, Bulek K, Della Mina E, Zhang Z, Pedergnana V, et al. Human Adaptive Immunity Rescues an Inborn Error of Innate Immunity. Cell. 2017;168:789-800.e10 pubmed 出版商
  89. Wouters K, Gaens K, Bijnen M, Verboven K, Jocken J, Wetzels S, et al. Circulating classical monocytes are associated with CD11c+ macrophages in human visceral adipose tissue. Sci Rep. 2017;7:42665 pubmed 出版商
  90. Perez Ruiz de Garibay A, Spinato C, Klippstein R, Bourgognon M, Martincic M, Pach E, et al. Evaluation of the immunological profile of antibody-functionalized metal-filled single-walled carbon nanocapsules for targeted radiotherapy. Sci Rep. 2017;7:42605 pubmed 出版商
  91. Canté Barrett K, Mendes R, Li Y, Vroegindeweij E, Pike Overzet K, Wabeke T, et al. Loss of CD44dim Expression from Early Progenitor Cells Marks T-Cell Lineage Commitment in the Human Thymus. Front Immunol. 2017;8:32 pubmed 出版商
  92. Aagaard K, Lahon A, Suter M, Arya R, Seferovic M, Vogt M, et al. Primary Human Placental Trophoblasts are Permissive for Zika Virus (ZIKV) Replication. Sci Rep. 2017;7:41389 pubmed 出版商
  93. Parrot T, Oger R, Benlalam H, Raingeard de la Blétière D, Jouand N, Coutolleau A, et al. CD40L confers helper functions to human intra-melanoma class-I-restricted CD4+CD8+ double positive T cells. Oncoimmunology. 2016;5:e1250991 pubmed 出版商
  94. Salvatori G, Foligno S, Sirleto P, Genovese S, Russo S, Coletti V, et al. Sometimes it is better to wait: First Italian case of a newborn with transient abnormal myelopoiesis and a favorable prognosis. Oncol Lett. 2017;13:191-195 pubmed 出版商
  95. An Q, Wang Y, Hu S, Fang D, Xuan C, Xu S, et al. Clinical significance of lymphocyte subset changes in hemophagocytic lymphohistiocytosis of children. Exp Ther Med. 2016;12:3549-3552 pubmed 出版商
  96. Wentink M, Dalm V, Lankester A, van Schouwenburg P, Schölvinck L, Kalina T, et al. Genetic defects in PI3K? affect B-cell differentiation and maturation leading to hypogammaglobulineamia and recurrent infections. Clin Immunol. 2017;176:77-86 pubmed 出版商
  97. Tauriainen J, Scharf L, Frederiksen J, Naji A, Ljunggren H, Sonnerborg A, et al. Perturbed CD8+ T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals. Sci Rep. 2017;7:40354 pubmed 出版商
  98. Lundell A, Nordström I, Andersson K, Lundqvist C, Telemo E, Nava S, et al. IFN type I and II induce BAFF secretion from human decidual stromal cells. Sci Rep. 2017;7:39904 pubmed 出版商
  99. van Andel H, Ren Z, Koopmans I, Joosten S, Kocemba K, de Lau W, et al. Aberrantly expressed LGR4 empowers Wnt signaling in multiple myeloma by hijacking osteoblast-derived R-spondins. Proc Natl Acad Sci U S A. 2017;114:376-381 pubmed 出版商
  100. Sairafi D, Stikvoort A, Gertow J, Mattsson J, Uhlin M. Donor Cell Composition and Reactivity Predict Risk of Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation. J Immunol Res. 2016;2016:5601204 pubmed
  101. Assadi G, Vesterlund L, Bonfiglio F, Mazzurana L, Cordeddu L, Schepis D, et al. Functional Analyses of the Crohn's Disease Risk Gene LACC1. PLoS ONE. 2016;11:e0168276 pubmed 出版商
  102. Cheng L, Ma J, Li J, Li D, Li G, Li F, et al. Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs. J Clin Invest. 2017;127:269-279 pubmed 出版商
  103. Matsuoka Y, Takahashi M, Sumide K, Kawamura H, Nakatsuka R, Fujioka T, et al. CD34 Antigen and the MPL Receptor Expression Defines a Novel Class of Human Cord Blood-Derived Primitive Hematopoietic Stem Cells. Cell Transplant. 2017;26:1043-1058 pubmed 出版商
  104. Lévy R, Okada S, Béziat V, Moriya K, Liu C, Chai L, et al. Genetic, immunological, and clinical features of patients with bacterial and fungal infections due to inherited IL-17RA deficiency. Proc Natl Acad Sci U S A. 2016;113:E8277-E8285 pubmed 出版商
  105. Ng S, Mitchell A, Kennedy J, Chen W, McLeod J, Ibrahimova N, et al. A 17-gene stemness score for rapid determination of risk in acute leukaemia. Nature. 2016;540:433-437 pubmed 出版商
  106. Zhu H, Hu F, Sun X, Zhang X, Zhu L, Liu X, et al. CD16+ Monocyte Subset Was Enriched and Functionally Exacerbated in Driving T-Cell Activation and B-Cell Response in Systemic Lupus Erythematosus. Front Immunol. 2016;7:512 pubmed
  107. Tomic A, Varanasi P, Golemac M, Malic S, Riese P, Borst E, et al. Activation of Innate and Adaptive Immunity by a Recombinant Human Cytomegalovirus Strain Expressing an NKG2D Ligand. PLoS Pathog. 2016;12:e1006015 pubmed 出版商
  108. Ribeiro S, Tesio M, Ribot J, Macintyre E, Barata J, Silva Santos B. Casein kinase 2 controls the survival of normal thymic and leukemic ?? T cells via promotion of AKT signaling. Leukemia. 2017;31:1603-1610 pubmed 出版商
  109. Oelsner S, Friede M, Zhang C, Wagner J, Badura S, Bader P, et al. Continuously expanding CAR NK-92 cells display selective cytotoxicity against B-cell leukemia and lymphoma. Cytotherapy. 2017;19:235-249 pubmed 出版商
  110. Siegers G, Barreira C, Postovit L, Dekaban G. CD11d ?2 integrin expression on human NK, B, and ?? T cells. J Leukoc Biol. 2017;101:1029-1035 pubmed 出版商
  111. Galindo Albarrán A, López Portales O, Gutiérrez Reyna D, Rodríguez Jorge O, Sánchez Villanueva J, Ramirez Pliego O, et al. CD8+ T Cells from Human Neonates Are Biased toward an Innate Immune Response. Cell Rep. 2016;17:2151-2160 pubmed 出版商
  112. Sherbenou D, Aftab B, Su Y, Behrens C, Wiita A, Logan A, et al. Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells. J Clin Invest. 2016;126:4640-4653 pubmed 出版商
  113. Dever D, Bak R, Reinisch A, Camarena J, Washington G, Nicolas C, et al. CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells. Nature. 2016;539:384-389 pubmed 出版商
  114. Casamayor Genescà A, Pla A, Oliver Vila I, Pujals Fonts N, Marín Gallén S, Caminal M, et al. Clinical-scale expansion of CD34+ cord blood cells amplifies committed progenitors and rapid scid repopulation cells. N Biotechnol. 2017;35:19-29 pubmed 出版商
  115. Sumatoh H, Teng K, Cheng Y, Newell E. Optimization of mass cytometry sample cryopreservation after staining. Cytometry A. 2017;91:48-61 pubmed 出版商
  116. Cuff A, Robertson F, Stegmann K, Pallett L, Maini M, Davidson B, et al. Eomeshi NK Cells in Human Liver Are Long-Lived and Do Not Recirculate but Can Be Replenished from the Circulation. J Immunol. 2016;197:4283-4291 pubmed
  117. Cheeseman H, Olejniczak N, Rogers P, Evans A, King D, Ziprin P, et al. Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies. J Virol. 2017;91: pubmed 出版商
  118. Serr I, Fürst R, Ott V, Scherm M, Nikolaev A, Gökmen F, et al. miRNA92a targets KLF2 and the phosphatase PTEN signaling to promote human T follicular helper precursors in T1D islet autoimmunity. Proc Natl Acad Sci U S A. 2016;113:E6659-E6668 pubmed
  119. Chung B, Guevel B, Reynolds G, Gupta Udatha D, Henriksen E, Stamataki Z, et al. Phenotyping and auto-antibody production by liver-infiltrating B cells in primary sclerosing cholangitis and primary biliary cholangitis. J Autoimmun. 2017;77:45-54 pubmed 出版商
  120. Massaad M, Zhou J, Tsuchimoto D, Chou J, Jabara H, Janssen E, et al. Deficiency of base excision repair enzyme NEIL3 drives increased predisposition to autoimmunity. J Clin Invest. 2016;126:4219-4236 pubmed 出版商
  121. Mascarell L, Airouche S, Berjont N, Gary C, Gueguen C, Fourcade G, et al. The regulatory dendritic cell marker C1q is a potent inhibitor of allergic inflammation. Mucosal Immunol. 2017;10:695-704 pubmed 出版商
  122. Oon S, Huynh H, Tai T, Ng M, Monaghan K, Biondo M, et al. A cytotoxic anti-IL-3Rα antibody targets key cells and cytokines implicated in systemic lupus erythematosus. JCI Insight. 2016;1:e86131 pubmed 出版商
  123. Albanese M, Tagawa T, Bouvet M, Maliqi L, Lutter D, Hoser J, et al. Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells. Proc Natl Acad Sci U S A. 2016;113:E6467-E6475 pubmed
  124. Roybal K, Williams J, Morsut L, Rupp L, Kolinko I, Choe J, et al. Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors. Cell. 2016;167:419-432.e16 pubmed 出版商
  125. Alivernini S, Kurowska Stolarska M, Tolusso B, Benvenuto R, Elmesmari A, Canestri S, et al. MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis. Nat Commun. 2016;7:12970 pubmed 出版商
  126. Willemen Y, Van den Bergh J, Bonte S, Anguille S, Heirman C, Stein B, et al. The tumor-associated antigen RHAMM (HMMR/CD168) is expressed by monocyte-derived dendritic cells and presented to T cells. Oncotarget. 2016;7:73960-73970 pubmed 出版商
  127. Clavarino G, Delouche N, Vettier C, Laurin D, Pernollet M, Raskovalova T, et al. Novel Strategy for Phenotypic Characterization of Human B Lymphocytes from Precursors to Effector Cells by Flow Cytometry. PLoS ONE. 2016;11:e0162209 pubmed 出版商
  128. Wang Y, Ma C, Ling Y, Bousfiha A, Camcioglu Y, Jacquot S, et al. Dual T cell- and B cell-intrinsic deficiency in humans with biallelic RLTPR mutations. J Exp Med. 2016;213:2413-2435 pubmed
  129. Sugita S, Iwasaki Y, Makabe K, Kimura T, Futagami T, Suegami S, et al. Lack of T Cell Response to iPSC-Derived Retinal Pigment Epithelial Cells from HLA Homozygous Donors. Stem Cell Reports. 2016;7:619-634 pubmed 出版商
  130. Wahid R, Fresnay S, Levine M, Sztein M. Cross-reactive multifunctional CD4+ T cell responses against Salmonella enterica serovars Typhi, Paratyphi A and Paratyphi B in humans following immunization with live oral typhoid vaccine Ty21a. Clin Immunol. 2016;173:87-95 pubmed 出版商
  131. Foerster F, Bamberger D, Schupp J, Weilbächer M, Kaps L, Strobl S, et al. Dextran-based therapeutic nanoparticles for hepatic drug delivery. Nanomedicine (Lond). 2016;11:2663-2677 pubmed
  132. Kelly A, Robinson M, Roche G, Biron C, O Farrelly C, Ryan E. Immune Cell Profiling of IFN-? Response Shows pDCs Express Highest Level of IFN-?R1 and Are Directly Responsive via the JAK-STAT Pathway. J Interferon Cytokine Res. 2016;36:671-680 pubmed
  133. Keefer M, Zheng B, Rosenberg A, Kobie J. Increased Steady-State Memory B Cell Subsets Among High-Risk Participants in an HIV Vaccine Trial. AIDS Res Hum Retroviruses. 2016;32:1143-1148 pubmed
  134. Pachnio A, Ciáurriz M, Begum J, Lal N, Zuo J, Beggs A, et al. Cytomegalovirus Infection Leads to Development of High Frequencies of Cytotoxic Virus-Specific CD4+ T Cells Targeted to Vascular Endothelium. PLoS Pathog. 2016;12:e1005832 pubmed 出版商
  135. Zenarruzabeitia O, Vitallé J, Garcia Obregon S, Astigarraga I, Eguizabal C, Santos S, et al. The expression and function of human CD300 receptors on blood circulating mononuclear cells are distinct in neonates and adults. Sci Rep. 2016;6:32693 pubmed 出版商
  136. Ferre E, Rose S, Rosenzweig S, Burbelo P, Romito K, Niemela J, et al. Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. JCI Insight. 2016;1: pubmed
  137. Ilkovitch D, Ferris L. Myeloid-derived suppressor cells are elevated in patients with psoriasis and produce various molecules. Mol Med Rep. 2016;14:3935-40 pubmed 出版商
  138. Landtwing V, Raykova A, Pezzino G, Beziat V, Marcenaro E, Graf C, et al. Cognate HLA absence in trans diminishes human NK cell education. J Clin Invest. 2016;126:3772-3782 pubmed 出版商
  139. Bentzen A, Marquard A, Lyngaa R, Saini S, Ramskov S, Donia M, et al. Large-scale detection of antigen-specific T cells using peptide-MHC-I multimers labeled with DNA barcodes. Nat Biotechnol. 2016;34:1037-1045 pubmed 出版商
  140. Bæk R, Søndergaard E, Varming K, Jørgensen M. The impact of various preanalytical treatments on the phenotype of small extracellular vesicles in blood analyzed by protein microarray. J Immunol Methods. 2016;438:11-20 pubmed 出版商
  141. Toro J, Salgado D, Vega R, Rodríguez J, Rodríguez L, Angel J, et al. Total and Envelope Protein-Specific Antibody-Secreting Cell Response in Pediatric Dengue Is Highly Modulated by Age and Subsequent Infections. PLoS ONE. 2016;11:e0161795 pubmed 出版商
  142. Huynh L, Kusnadi A, Park S, Murata K, Park Min K, Ivashkiv L. Opposing regulation of the late phase TNF response by mTORC1-IL-10 signaling and hypoxia in human macrophages. Sci Rep. 2016;6:31959 pubmed 出版商
  143. Mercer F, Diala F, Chen Y, Molgora B, Ng S, Johnson P. Leukocyte Lysis and Cytokine Induction by the Human Sexually Transmitted Parasite Trichomonas vaginalis. PLoS Negl Trop Dis. 2016;10:e0004913 pubmed 出版商
  144. Watson D, Bayık D, Srivatsan A, Bergamaschi C, Valentin A, Niu G, et al. Efficient production and enhanced tumor delivery of engineered extracellular vesicles. Biomaterials. 2016;105:195-205 pubmed 出版商
  145. Yao Y, Deng Q, Song W, Zhang H, Li Y, Yang Y, et al. MIF Plays a Key Role in Regulating Tissue-Specific Chondro-Osteogenic Differentiation Fate of Human Cartilage Endplate Stem Cells under Hypoxia. Stem Cell Reports. 2016;7:249-62 pubmed 出版商
  146. Leong Y, Chen Y, Ong H, Wu D, Man K, Deléage C, et al. CXCR5(+) follicular cytotoxic T cells control viral infection in B cell follicles. Nat Immunol. 2016;17:1187-96 pubmed 出版商
  147. Demers K, Makedonas G, Buggert M, Eller M, Ratcliffe S, Goonetilleke N, et al. Temporal Dynamics of CD8+ T Cell Effector Responses during Primary HIV Infection. PLoS Pathog. 2016;12:e1005805 pubmed 出版商
  148. Cerny D, Thi Le D, The T, Zuest R, Kg S, Velumani S, et al. Complete human CD1a deficiency on Langerhans cells due to a rare point mutation in the coding sequence. J Allergy Clin Immunol. 2016;138:1709-1712.e11 pubmed 出版商
  149. Paquin Proulx D, Gibbs A, Bachle S, Checa A, Introini A, Leeansyah E, et al. Innate Invariant NKT Cell Recognition of HIV-1-Infected Dendritic Cells Is an Early Detection Mechanism Targeted by Viral Immune Evasion. J Immunol. 2016;197:1843-51 pubmed 出版商
  150. Debliquis A, Voirin J, Harzallah I, Maurer M, Lerintiu F, Drenou B, et al. Cytomorphology and flow cytometry of brain biopsy rinse fluid enables faster and multidisciplinary diagnosis of large B-cell lymphoma of the central nervous system. Cytometry B Clin Cytom. 2018;94:182-188 pubmed 出版商
  151. Sullivan K, Lewis H, Hill A, Pandey A, Jackson L, Cabral J, et al. Trisomy 21 consistently activates the interferon response. elife. 2016;5: pubmed 出版商
  152. Jacoby E, Nguyen S, Fountaine T, Welp K, Gryder B, Qin H, et al. CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity. Nat Commun. 2016;7:12320 pubmed 出版商
  153. Ashizawa T, Iizuka A, Nonomura C, Kondou R, Maeda C, Miyata H, et al. Antitumor Effect of Programmed Death-1 (PD-1) Blockade in Humanized the NOG-MHC Double Knockout Mouse. Clin Cancer Res. 2017;23:149-158 pubmed 出版商
  154. Neumann L, Mueller M, Moos V, Heller F, Meyer T, Loddenkemper C, et al. Mucosal Inducible NO Synthase-Producing IgA+ Plasma Cells in Helicobacter pylori-Infected Patients. J Immunol. 2016;197:1801-8 pubmed 出版商
  155. Sadallah S, Schmied L, Eken C, Charoudeh H, Amicarella F, Schifferli J. Platelet-Derived Ectosomes Reduce NK Cell Function. J Immunol. 2016;197:1663-71 pubmed 出版商
  156. Fromentin R, Bakeman W, Lawani M, Khoury G, Hartogensis W, DaFonseca S, et al. CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART. PLoS Pathog. 2016;12:e1005761 pubmed 出版商
  157. Piancone F, Saresella M, Marventano I, La Rosa F, Zoppis M, Agostini S, et al. B Lymphocytes in Multiple Sclerosis: Bregs and BTLA/CD272 Expressing-CD19+ Lymphocytes Modulate Disease Severity. Sci Rep. 2016;6:29699 pubmed 出版商
  158. Di Liberto D, Mansueto P, D Alcamo A, Lo Pizzo M, Lo Presti E, Geraci G, et al. Predominance of Type 1 Innate Lymphoid Cells in the Rectal Mucosa of Patients With Non-Celiac Wheat Sensitivity: Reversal After a Wheat-Free Diet. Clin Transl Gastroenterol. 2016;7:e178 pubmed 出版商
  159. Piepenbrink M, Samuel M, Zheng B, Carter B, Fucile C, Bunce C, et al. Humoral Dysregulation Associated with Increased Systemic Inflammation among Injection Heroin Users. PLoS ONE. 2016;11:e0158641 pubmed 出版商
  160. Ellebrecht C, Bhoj V, Nace A, Choi E, Mao X, Cho M, et al. Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease. Science. 2016;353:179-84 pubmed 出版商
  161. Wittmann A, Lamprinaki D, Bowles K, Katzenellenbogen E, Knirel Y, Whitfield C, et al. Dectin-2 Recognizes Mannosylated O-antigens of Human Opportunistic Pathogens and Augments Lipopolysaccharide Activation of Myeloid Cells. J Biol Chem. 2016;291:17629-38 pubmed 出版商
  162. Stadinski B, Shekhar K, Gomez Tourino I, Jung J, Sasaki K, Sewell A, et al. Hydrophobic CDR3 residues promote the development of self-reactive T cells. Nat Immunol. 2016;17:946-55 pubmed 出版商
  163. Ebert L, Tan L, Johan M, Min K, Cockshell M, Parham K, et al. A non-canonical role for desmoglein-2 in endothelial cells: implications for neoangiogenesis. Angiogenesis. 2016;19:463-86 pubmed 出版商
  164. Cheng W, van Asten S, Burns L, Evans H, Walter G, Hashim A, et al. Periodontitis-associated pathogens P. gingivalis and A. actinomycetemcomitans activate human CD14(+) monocytes leading to enhanced Th17/IL-17 responses. Eur J Immunol. 2016;46:2211-21 pubmed 出版商
  165. Ramos C, Savoldo B, Torrano V, Ballard B, Zhang H, Dakhova O, et al. Clinical responses with T lymphocytes targeting malignancy-associated ? light chains. J Clin Invest. 2016;126:2588-96 pubmed 出版商
  166. van der Heiden M, van Zelm M, Bartol S, de Rond L, Berbers G, Boots A, et al. Differential effects of Cytomegalovirus carriage on the immune phenotype of middle-aged males and females. Sci Rep. 2016;6:26892 pubmed 出版商
  167. Vaccari M, Gordon S, Fourati S, Schifanella L, Liyanage N, Cameron M, et al. Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition. Nat Med. 2016;22:762-70 pubmed 出版商
  168. Reinisch A, Thomas D, Corces M, Zhang X, Gratzinger D, Hong W, et al. A humanized bone marrow ossicle xenotransplantation model enables improved engraftment of healthy and leukemic human hematopoietic cells. Nat Med. 2016;22:812-21 pubmed 出版商
  169. Burger J, Landau D, Taylor Weiner A, Bozic I, Zhang H, Sarosiek K, et al. Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition. Nat Commun. 2016;7:11589 pubmed 出版商
  170. Göbel K, Pankratz S, Asaridou C, Herrmann A, Bittner S, Merker M, et al. Blood coagulation factor XII drives adaptive immunity during neuroinflammation via CD87-mediated modulation of dendritic cells. Nat Commun. 2016;7:11626 pubmed 出版商
  171. Shi H, Cao N, Pu Y, Xie L, Zheng L, Yu C. Long non-coding RNA expression profile in minor salivary gland of primary Sjögren's syndrome. Arthritis Res Ther. 2016;18:109 pubmed 出版商
  172. Dou D, Calvanese V, Sierra M, Nguyen A, Minasian A, Saarikoski P, et al. Medial HOXA genes demarcate haematopoietic stem cell fate during human development. Nat Cell Biol. 2016;18:595-606 pubmed 出版商
  173. Theorell J, Bryceson Y. Analysis of Intracellular Ca(2+) Mobilization in Human NK Cell Subsets by Flow Cytometry. Methods Mol Biol. 2016;1441:117-30 pubmed 出版商
  174. Kay A, Strauss Albee D, Blish C. Application of Mass Cytometry (CyTOF) for Functional and Phenotypic Analysis of Natural Killer Cells. Methods Mol Biol. 2016;1441:13-26 pubmed 出版商
  175. Hohos N, Lee K, Ji L, Yu M, Kandasamy M, Phillips B, et al. DNA cytosine hydroxymethylation levels are distinct among non-overlapping classes of peripheral blood leukocytes. J Immunol Methods. 2016;436:1-15 pubmed 出版商
  176. Stikvoort A, Sundin M, Uzunel M, Gertow J, Sundberg B, Schaffer M, et al. Long-Term Stable Mixed Chimerism after Hematopoietic Stem Cell Transplantation in Patients with Non-Malignant Disease, Shall We Be Tolerant?. PLoS ONE. 2016;11:e0154737 pubmed 出版商
  177. Yu C, Liu Y, Chan J, Tong J, Li Z, Shi M, et al. Identification of human plasma cells with a lamprey monoclonal antibody. JCI Insight. 2016;1: pubmed
  178. Cook A, McDonnell A, Lake R, Nowak A. Dexamethasone co-medication in cancer patients undergoing chemotherapy causes substantial immunomodulatory effects with implications for chemo-immunotherapy strategies. Oncoimmunology. 2016;5:e1066062 pubmed
  179. Rentas S, Holzapfel N, Belew M, Pratt G, Voisin V, Wilhelm B, et al. Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells. Nature. 2016;532:508-511 pubmed 出版商
  180. Qualai J, Li L, Cantero J, Tarrats A, Fernández M, Sumoy L, et al. Expression of CD11c Is Associated with Unconventional Activated T Cell Subsets with High Migratory Potential. PLoS ONE. 2016;11:e0154253 pubmed 出版商
  181. Bal S, Bernink J, Nagasawa M, Groot J, Shikhagaie M, Golebski K, et al. IL-1?, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs. Nat Immunol. 2016;17:636-45 pubmed 出版商
  182. Lisenko K, Schonland S, Jauch A, Andrulis M, Rocken C, Ho A, et al. Flow cytometry-based characterization of underlying clonal B and plasma cells in patients with light chain amyloidosis. Cancer Med. 2016;5:1464-72 pubmed 出版商
  183. Belov L, Matic K, Hallal S, Best O, Mulligan S, Christopherson R. Extensive surface protein profiles of extracellular vesicles from cancer cells may provide diagnostic signatures from blood samples. J Extracell Vesicles. 2016;5:25355 pubmed 出版商
  184. Yamashita K, Kawata K, Matsumiya H, Kamekura R, Jitsukawa S, Nagaya T, et al. Bob1 limits cellular frequency of T-follicular helper cells. Eur J Immunol. 2016;46:1361-70 pubmed 出版商
  185. Li H, Borrego F, Nagata S, Tolnay M. Fc Receptor-like 5 Expression Distinguishes Two Distinct Subsets of Human Circulating Tissue-like Memory B Cells. J Immunol. 2016;196:4064-74 pubmed 出版商
  186. Jackson S, Jacobs H, Arkatkar T, Dam E, Scharping N, Kolhatkar N, et al. B cell IFN-γ receptor signaling promotes autoimmune germinal centers via cell-intrinsic induction of BCL-6. J Exp Med. 2016;213:733-50 pubmed 出版商
  187. Malkiel S, Jeganathan V, Wolfson S, Manjarrez Orduno N, Marasco E, Aranow C, et al. Checkpoints for Autoreactive B Cells in the Peripheral Blood of Lupus Patients Assessed by Flow Cytometry. Arthritis Rheumatol. 2016;68:2210-20 pubmed 出版商
  188. Jourdan M, Cren M, Schafer P, Robert N, Duperray C, Vincent L, et al. Differential effects of lenalidomide during plasma cell differentiation. Oncotarget. 2016;7:28096-111 pubmed 出版商
  189. Brown P, Gascoyne D, Lyne L, Spearman H, Felce S, McFadden N, et al. N-terminally truncated FOXP1 protein expression and alternate internal FOXP1 promoter usage in normal and malignant B cells. Haematologica. 2016;101:861-71 pubmed 出版商
  190. Komori M, Lin Y, Cortese I, Blake A, Ohayon J, Cherup J, et al. Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis. Ann Clin Transl Neurol. 2016;3:166-79 pubmed 出版商
  191. Yigit B, Halibozek P, Chen S, O Keeffe M, Arnason J, Avigan D, et al. A combination of an anti-SLAMF6 antibody and ibrutinib efficiently abrogates expansion of chronic lymphocytic leukemia cells. Oncotarget. 2016;7:26346-60 pubmed 出版商
  192. Jardine J, Kulp D, Havenar Daughton C, Sarkar A, Briney B, Sok D, et al. HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen. Science. 2016;351:1458-63 pubmed 出版商
  193. Leone D, Kozakowski N, Kornauth C, Waidacher T, Neudert B, Loeffler A, et al. The Phenotypic Characterization of the Human Renal Mononuclear Phagocytes Reveal a Co-Ordinated Response to Injury. PLoS ONE. 2016;11:e0151674 pubmed 出版商
  194. Lao X, Liang Y, Su Y, Zhang S, Zhou X, Liao G. Distribution and significance of interstitial fibrosis and stroma-infiltrating B cells in tongue squamous cell carcinoma. Oncol Lett. 2016;11:2027-2034 pubmed
  195. Lee Chang C, Bodogai M, Moritoh K, Chen X, Wersto R, Sen R, et al. Aging Converts Innate B1a Cells into Potent CD8+ T Cell Inducers. J Immunol. 2016;196:3385-97 pubmed 出版商
  196. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed 出版商
  197. Flint S, Gibson A, Lucas G, Nandigam R, Taylor L, Provan D, et al. A distinct plasmablast and naïve B-cell phenotype in primary immune thrombocytopenia. Haematologica. 2016;101:698-706 pubmed 出版商
  198. Cheong T, Compagno M, Chiarle R. Editing of mouse and human immunoglobulin genes by CRISPR-Cas9 system. Nat Commun. 2016;7:10934 pubmed 出版商
  199. Rombout A, Lust S, Offner F, Naessens E, Verhasselt B, Philippé J. Mimicking the tumour microenvironment of chronic lymphocytic leukaemia in vitro critically depends on the type of B-cell receptor stimulation. Br J Cancer. 2016;114:704-12 pubmed 出版商
  200. Zondler L, Müller K, Khalaji S, Bliederhäuser C, Ruf W, Grozdanov V, et al. Peripheral monocytes are functionally altered and invade the CNS in ALS patients. Acta Neuropathol. 2016;132:391-411 pubmed 出版商
  201. Clemente Casares X, Blanco J, Ambalavanan P, Yamanouchi J, Singha S, Fandos C, et al. Expanding antigen-specific regulatory networks to treat autoimmunity. Nature. 2016;530:434-40 pubmed 出版商
  202. Klose D, Saunders U, Barth S, Fischer R, Jacobi A, Nachreiner T. Novel fusion proteins for the antigen-specific staining and elimination of B cell receptor-positive cell populations demonstrated by a tetanus toxoid fragment C (TTC) model antigen. BMC Biotechnol. 2016;16:18 pubmed 出版商
  203. Chang C, Hale S, Cox C, Blair A, Kronsteiner B, Grabowska R, et al. Junctional Adhesion Molecule-A Is Highly Expressed on Human Hematopoietic Repopulating Cells and Associates with the Key Hematopoietic Chemokine Receptor CXCR4. Stem Cells. 2016;34:1664-78 pubmed 出版商
  204. Ludigs K, Jandus C, Utzschneider D, Staehli F, Bessoles S, Dang A, et al. NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditions. Nat Commun. 2016;7:10554 pubmed 出版商
  205. Llibre A, López Macías C, Marafioti T, Mehta H, Partridge A, Kanzig C, et al. LLT1 and CD161 Expression in Human Germinal Centers Promotes B Cell Activation and CXCR4 Downregulation. J Immunol. 2016;196:2085-94 pubmed 出版商
  206. Roan F, Stoklasek T, Whalen E, Molitor J, Bluestone J, Buckner J, et al. CD4+ Group 1 Innate Lymphoid Cells (ILC) Form a Functionally Distinct ILC Subset That Is Increased in Systemic Sclerosis. J Immunol. 2016;196:2051-2062 pubmed 出版商
  207. Somasundaram V, Soni S, Chopra A, Rai S, Mahapatra M, Kumar R, et al. Value of Quantitative assessment of Myeloid Nuclear Differentiation Antigen expression and other flow cytometric parameters in the diagnosis of Myelodysplastic syndrome. Int J Lab Hematol. 2016;38:141-50 pubmed 出版商
  208. Dang M, Bradford C, Pozzilli P, Leslie R. Methylation Analysis in Distinct Immune Cell Subsets in Type 1 Diabetes. Methods Mol Biol. 2016;1433:143-51 pubmed 出版商
  209. Kanderová V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, et al. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells. Mol Cell Proteomics. 2016;15:1246-61 pubmed 出版商
  210. Zhu N, Wang H, Wang B, Wei J, Shan W, Feng J, et al. A Member of the Nuclear Receptor Superfamily, Designated as NR2F2, Supports the Self-Renewal Capacity and Pluripotency of Human Bone Marrow-Derived Mesenchymal Stem Cells. Stem Cells Int. 2016;2016:5687589 pubmed 出版商
  211. Vargas Inchaustegui D, Demers A, Shaw J, Kang G, Ball D, Tuero I, et al. Vaccine Induction of Lymph Node-Resident Simian Immunodeficiency Virus Env-Specific T Follicular Helper Cells in Rhesus Macaques. J Immunol. 2016;196:1700-10 pubmed 出版商
  212. Gonzalez S, Taborda N, Correa L, Castro G, Hernandez J, Montoya C, et al. Particular activation phenotype of T cells expressing HLA-DR but not CD38 in GALT from HIV-controllers is associated with immune regulation and delayed progression to AIDS. Immunol Res. 2016;64:765-74 pubmed 出版商
  213. Karlsson H, Svensson E, Gigg C, Jarvius M, Olsson Strömberg U, Savoldo B, et al. Evaluation of Intracellular Signaling Downstream Chimeric Antigen Receptors. PLoS ONE. 2015;10:e0144787 pubmed 出版商
  214. Weinstein S, Toker I, Emmanuel R, Ramishetti S, Hazan Halevy I, Rosenblum D, et al. Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies. Proc Natl Acad Sci U S A. 2016;113:E16-22 pubmed 出版商
  215. Arriaga Pizano L, Ferat Osorio E, Rodríguez Abrego G, Mancilla Herrera I, Domínguez Cerezo E, Valero Pacheco N, et al. Differential Immune Profiles in Two Pandemic Influenza A(H1N1)pdm09 Virus Waves at Pandemic Epicenter. Arch Med Res. 2015;46:651-8 pubmed 出版商
  216. Lisenko K, Schönland S, Hegenbart U, Wallenwein K, Braun U, Mai E, et al. Potential therapeutic targets in plasma cell disorders: A flow cytometry study. Cytometry B Clin Cytom. 2017;92:145-152 pubmed 出版商
  217. Westman J, Papareddy P, Dahlgren M, Chakrakodi B, Norrby Teglund A, Smeds E, et al. Extracellular Histones Induce Chemokine Production in Whole Blood Ex Vivo and Leukocyte Recruitment In Vivo. PLoS Pathog. 2015;11:e1005319 pubmed 出版商
  218. Jabara H, Boyden S, Chou J, Ramesh N, Massaad M, Benson H, et al. A missense mutation in TFRC, encoding transferrin receptor 1, causes combined immunodeficiency. Nat Genet. 2016;48:74-8 pubmed 出版商
  219. Yamagishi M, Katano H, Hishima T, Shimoyama T, Ota Y, Nakano K, et al. Coordinated loss of microRNA group causes defenseless signaling in malignant lymphoma. Sci Rep. 2015;5:17868 pubmed 出版商
  220. Günther S, Ostheimer C, Stangl S, Specht H, Mózes P, Jesinghaus M, et al. Correlation of Hsp70 Serum Levels with Gross Tumor Volume and Composition of Lymphocyte Subpopulations in Patients with Squamous Cell and Adeno Non-Small Cell Lung Cancer. Front Immunol. 2015;6:556 pubmed 出版商
  221. Laner Plamberger S, Lener T, Schmid D, Streif D, Salzer T, Öller M, et al. Mechanical fibrinogen-depletion supports heparin-free mesenchymal stem cell propagation in human platelet lysate. J Transl Med. 2015;13:354 pubmed 出版商
  222. Notta F, Zandi S, Takayama N, Dobson S, Gan O, Wilson G, et al. Distinct routes of lineage development reshape the human blood hierarchy across ontogeny. Science. 2016;351:aab2116 pubmed 出版商
  223. Bhat N, Adams C, Chen Y, Bieber M, Teng N. Identification of Cell Surface Straight Chain Poly-N-Acetyl-Lactosamine Bearing Protein Ligands for VH4-34-Encoded Natural IgM Antibodies. J Immunol. 2015;195:5178-88 pubmed 出版商
  224. Cox K, Tang A, Chen Z, Horton M, Yan H, Wang X, et al. Rapid isolation of dengue-neutralizing antibodies from single cell-sorted human antigen-specific memory B-cell cultures. MAbs. 2016;8:129-40 pubmed 出版商
  225. Venkatasubramanian S, Tripathi D, Tucker T, Paidipally P, Cheekatla S, Welch E, et al. Tissue factor expression by myeloid cells contributes to protective immune response against Mycobacterium tuberculosis infection. Eur J Immunol. 2016;46:464-79 pubmed 出版商
  226. Newell K, Asare A, Sanz I, Wei C, Rosenberg A, Gao Z, et al. Longitudinal studies of a B cell-derived signature of tolerance in renal transplant recipients. Am J Transplant. 2015;15:2908-20 pubmed 出版商
  227. Schulz A, Mälzer J, Domingo C, Jürchott K, Grützkau A, Babel N, et al. Low Thymic Activity and Dendritic Cell Numbers Are Associated with the Immune Response to Primary Viral Infection in Elderly Humans. J Immunol. 2015;195:4699-711 pubmed 出版商
  228. Okoye Okafor U, Bartholdy B, Cartier J, Gao E, Pietrak B, Rendina A, et al. New IDH1 mutant inhibitors for treatment of acute myeloid leukemia. Nat Chem Biol. 2015;11:878-86 pubmed 出版商
  229. Dai B, Chen A, Corkum C, Peroutka R, Landon A, Houng S, et al. Hepatitis C virus upregulates B-cell receptor signaling: a novel mechanism for HCV-associated B-cell lymphoproliferative disorders. Oncogene. 2016;35:2979-90 pubmed 出版商
  230. McCausland M, Juchnowski S, Zidar D, Kuritzkes D, Andrade A, Sieg S, et al. Altered Monocyte Phenotype in HIV-1 Infection Tends to Normalize with Integrase-Inhibitor-Based Antiretroviral Therapy. PLoS ONE. 2015;10:e0139474 pubmed 出版商
  231. Gonzalez N, Wennhold K, Balkow S, Kondo E, Bölck B, Weber T, et al. In vitro and in vivo imaging of initial B-T-cell interactions in the setting of B-cell based cancer immunotherapy. Oncoimmunology. 2015;4:e1038684 pubmed
  232. Fong C, Gilan O, Lam E, Rubin A, Ftouni S, Tyler D, et al. BET inhibitor resistance emerges from leukaemia stem cells. Nature. 2015;525:538-42 pubmed 出版商
  233. Campi Azevedo A, Costa Pereira C, Antonelli L, Fonseca C, Teixeira Carvalho A, Villela Rezende G, et al. Booster dose after 10 years is recommended following 17DD-YF primary vaccination. Hum Vaccin Immunother. 2016;12:491-502 pubmed 出版商
  234. Andersson K, Brisslert M, Cavallini N, Svensson M, Welin A, Erlandsson M, et al. Survivin co-ordinates formation of follicular T-cells acting in synergy with Bcl-6. Oncotarget. 2015;6:20043-57 pubmed
  235. Chen X, Li W, Zhang Y, Song X, Xu L, Xu Z, et al. Distribution of Peripheral Memory T Follicular Helper Cells in Patients with Schistosomiasis Japonica. PLoS Negl Trop Dis. 2015;9:e0004015 pubmed 出版商
  236. Cui X, Zhang L, Magli A, Catera R, Yan X, Griffin D, et al. Cytoplasmic myosin-exposed apoptotic cells appear with caspase-3 activation and enhance CLL cell viability. Leukemia. 2016;30:74-85 pubmed 出版商
  237. Wostradowski T, Gudi V, Pul R, Gingele S, Lindquist J, Stangel M, et al. Effect of interferon-β1b on CXCR4-dependent chemotaxis in T cells from multiple sclerosis patients. Clin Exp Immunol. 2015;182:162-72 pubmed 出版商
  238. Mende N, Kuchen E, Lesche M, Grinenko T, Kokkaliaris K, Hanenberg H, et al. CCND1-CDK4-mediated cell cycle progression provides a competitive advantage for human hematopoietic stem cells in vivo. J Exp Med. 2015;212:1171-83 pubmed 出版商
  239. Chalan P, Bijzet J, Huitema M, Kroesen B, Brouwer E, Boots A. Expression of Lectin-Like Transcript 1, the Ligand for CD161, in Rheumatoid Arthritis. PLoS ONE. 2015;10:e0132436 pubmed 出版商
  240. Saulep Easton D, Vincent F, Quah P, Wei A, Ting S, Croce C, et al. The BAFF receptor TACI controls IL-10 production by regulatory B cells and CLL B cells. Leukemia. 2016;30:163-72 pubmed 出版商
  241. Pojero F, Flores Montero J, Sanoja L, Pérez J, Puig N, Paiva B, et al. Utility of CD54, CD229, and CD319 for the identification of plasma cells in patients with clonal plasma cell diseases. Cytometry B Clin Cytom. 2016;90:91-100 pubmed 出版商
  242. Elong Ngono A, Lepetit M, Reindl M, Garcia A, Guillot F, Genty A, et al. Decreased Frequency of Circulating Myelin Oligodendrocyte Glycoprotein B Lymphocytes in Patients with Relapsing-Remitting Multiple Sclerosis. J Immunol Res. 2015;2015:673503 pubmed 出版商
  243. Perriard G, Mathias A, Enz L, Canales M, Schluep M, Gentner M, et al. Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes. J Neuroinflammation. 2015;12:119 pubmed 出版商
  244. Lee J, Breton G, Aljoufi A, Zhou Y, PUHR S, Nussenzweig M, et al. Clonal analysis of human dendritic cell progenitor using a stromal cell culture. J Immunol Methods. 2015;425:21-6 pubmed 出版商
  245. Rasmussen T, Andersen T, Bak R, Yiu G, Sørensen C, Stengaard Pedersen K, et al. Overexpression of microRNA-155 increases IL-21 mediated STAT3 signaling and IL-21 production in systemic lupus erythematosus. Arthritis Res Ther. 2015;17:154 pubmed 出版商
  246. Wielgosz M, Kim Y, Carney G, Zhan J, Reddivari M, Coop T, et al. Generation of a lentiviral vector producer cell clone for human Wiskott-Aldrich syndrome gene therapy. Mol Ther Methods Clin Dev. 2015;2:14063 pubmed 出版商
  247. Mathur R, Sehgal L, Braun F, Berkova Z, Romaguerra J, Wang M, et al. Targeting Wnt pathway in mantle cell lymphoma-initiating cells. J Hematol Oncol. 2015;8:63 pubmed 出版商
  248. Kerkman P, Fabre E, van der Voort E, Zaldumbide A, Rombouts Y, Rispens T, et al. Identification and characterisation of citrullinated antigen-specific B cells in peripheral blood of patients with rheumatoid arthritis. Ann Rheum Dis. 2016;75:1170-6 pubmed 出版商
  249. Kim S, Theunissen J, Balibalos J, Liao Chan S, Babcock M, Wong T, et al. A novel antibody-drug conjugate targeting SAIL for the treatment of hematologic malignancies. Blood Cancer J. 2015;5:e316 pubmed 出版商
  250. Boisson B, Laplantine E, Dobbs K, Cobat A, Tarantino N, Hazen M, et al. Human HOIP and LUBAC deficiency underlies autoinflammation, immunodeficiency, amylopectinosis, and lymphangiectasia. J Exp Med. 2015;212:939-51 pubmed 出版商
  251. Tipton C, Fucile C, DARCE J, Chida A, Ichikawa T, Gregoretti I, et al. Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus. Nat Immunol. 2015;16:755-65 pubmed 出版商
  252. Zhu D, Wang Z, Zhao J, Calimeri T, Meng J, Hideshima T, et al. The Cyclophilin A-CD147 complex promotes the proliferation and homing of multiple myeloma cells. Nat Med. 2015;21:572-80 pubmed 出版商
  253. McArthur M, Fresnay S, Magder L, Darton T, Jones C, Waddington C, et al. Activation of Salmonella Typhi-specific regulatory T cells in typhoid disease in a wild-type S. Typhi challenge model. PLoS Pathog. 2015;11:e1004914 pubmed 出版商
  254. Holzapfel B, Hutmacher D, Nowlan B, Barbier V, Thibaudeau L, Theodoropoulos C, et al. Tissue engineered humanized bone supports human hematopoiesis in vivo. Biomaterials. 2015;61:103-14 pubmed 出版商
  255. Wang Z, Wan Y, Qiu C, Quiñones Parra S, Zhu Z, Loh L, et al. Recovery from severe H7N9 disease is associated with diverse response mechanisms dominated by CD8⁺ T cells. Nat Commun. 2015;6:6833 pubmed 出版商
  256. de Winde C, Zuidscherwoude M, Vasaturo A, van der Schaaf A, Figdor C, van Spriel A. Multispectral imaging reveals the tissue distribution of tetraspanins in human lymphoid organs. Histochem Cell Biol. 2015;144:133-46 pubmed 出版商
  257. Boer M, Prins C, van Meijgaarden K, van Dissel J, Ottenhoff T, Joosten S. Mycobacterium bovis BCG Vaccination Induces Divergent Proinflammatory or Regulatory T Cell Responses in Adults. Clin Vaccine Immunol. 2015;22:778-88 pubmed 出版商
  258. Bhat N, Kshirsagar M, Bieber M, Teng N. IgG Subclasses and Isotypes of VH4-34 Encoded Antibodies. Immunol Invest. 2015;44:400-10 pubmed 出版商
  259. Berent Maoz B, Montecino Rodriguez E, Fice M, Casero D, Seet C, Crooks G, et al. The expansion of thymopoiesis in neonatal mice is dependent on expression of high mobility group a 2 protein (Hmga2). PLoS ONE. 2015;10:e0125414 pubmed 出版商
  260. Anandasabapathy N, Breton G, Hurley A, Caskey M, Trumpfheller C, Sarma P, et al. Efficacy and safety of CDX-301, recombinant human Flt3L, at expanding dendritic cells and hematopoietic stem cells in healthy human volunteers. Bone Marrow Transplant. 2015;50:924-30 pubmed 出版商
  261. Fromm J, Tagliente D, Shaver A, Neppalli V, Craig F. Case study interpretation: Report from the ICCS Annual Meeting, Seattle, 2014. Cytometry B Clin Cytom. 2015;88:413-24 pubmed 出版商
  262. Dyring Andersen B, Bonefeld C, Bzorek M, Løvendorf M, Lauritsen J, Skov L, et al. The Vitamin D Analogue Calcipotriol Reduces the Frequency of CD8+ IL-17+ T Cells in Psoriasis Lesions. Scand J Immunol. 2015;82:84-91 pubmed 出版商
  263. Mahmood Z, Muhammad K, Schmalzing M, Roll P, Dörner T, Tony H. CD27-IgD- memory B cells are modulated by in vivo interleukin-6 receptor (IL-6R) blockade in rheumatoid arthritis. Arthritis Res Ther. 2015;17:61 pubmed 出版商
  264. Weinberg A, Muresan P, Richardson K, Fenton T, Domínguez T, Bloom A, et al. Determinants of vaccine immunogenicity in HIV-infected pregnant women: analysis of B and T cell responses to pandemic H1N1 monovalent vaccine. PLoS ONE. 2015;10:e0122431 pubmed 出版商
  265. Jørgensen M, Bæk R, Varming K. Potentials and capabilities of the Extracellular Vesicle (EV) Array. J Extracell Vesicles. 2015;4:26048 pubmed 出版商
  266. Schilling D, Kühnel A, Tetzlaff F, Konrad S, Multhoff G. NZ28-induced inhibition of HSF1, SP1 and NF-κB triggers the loss of the natural killer cell-activating ligands MICA/B on human tumor cells. Cancer Immunol Immunother. 2015;64:599-608 pubmed 出版商
  267. Inglis H, Danesh A, Shah A, Lacroix J, Spinella P, Norris P. Techniques to improve detection and analysis of extracellular vesicles using flow cytometry. Cytometry A. 2015;87:1052-63 pubmed 出版商
  268. Chen Z, Shojaee S, Buchner M, Geng H, Lee J, Klemm L, et al. Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemia. Nature. 2015;521:357-61 pubmed 出版商
  269. Misra R, Shah S, Fowell D, Wang H, Scheible K, Misra S, et al. Preterm cord blood CD4⁺ T cells exhibit increased IL-6 production in chorioamnionitis and decreased CD4⁺ T cells in bronchopulmonary dysplasia. Hum Immunol. 2015;76:329-338 pubmed 出版商
  270. Castiello M, Scaramuzza S, Pala F, Ferrua F, Uva P, Brigida I, et al. B-cell reconstitution after lentiviral vector-mediated gene therapy in patients with Wiskott-Aldrich syndrome. J Allergy Clin Immunol. 2015;136:692-702.e2 pubmed 出版商
  271. Ohnuma K, Hatano R, Aune T, Otsuka H, Iwata S, Dang N, et al. Regulation of pulmonary graft-versus-host disease by IL-26+CD26+CD4 T lymphocytes. J Immunol. 2015;194:3697-712 pubmed 出版商
  272. Inui M, Hirota S, Hirano K, Fujii H, Sugahara Tobinai A, Ishii T, et al. Human CD43+ B cells are closely related not only to memory B cells phenotypically but also to plasmablasts developmentally in healthy individuals. Int Immunol. 2015;27:345-55 pubmed 出版商
  273. Holmfeldt L, Mullighan C. Generation of human acute lymphoblastic leukemia xenografts for use in oncology drug discovery. Curr Protoc Pharmacol. 2015;68:14.32.1-19 pubmed 出版商
  274. Martínez Torres A, Quiney C, Attout T, Boullet H, Herbi L, Vela L, et al. CD47 agonist peptides induce programmed cell death in refractory chronic lymphocytic leukemia B cells via PLCγ1 activation: evidence from mice and humans. PLoS Med. 2015;12:e1001796 pubmed 出版商
  275. Lee J, Breton G, Oliveira T, Zhou Y, Aljoufi A, PUHR S, et al. Restricted dendritic cell and monocyte progenitors in human cord blood and bone marrow. J Exp Med. 2015;212:385-99 pubmed 出版商
  276. Marquardt N, Béziat V, Nyström S, Hengst J, Ivarsson M, Kekäläinen E, et al. Cutting edge: identification and characterization of human intrahepatic CD49a+ NK cells. J Immunol. 2015;194:2467-71 pubmed 出版商
  277. Boyle M, Jagannathan P, Bowen K, McIntyre T, Vance H, Farrington L, et al. Effector Phenotype of Plasmodium falciparum-Specific CD4+ T Cells Is Influenced by Both Age and Transmission Intensity in Naturally Exposed Populations. J Infect Dis. 2015;212:416-25 pubmed 出版商
  278. García Carmona Y, Cols M, Ting A, Radigan L, Yuk F, Zhang L, et al. Differential induction of plasma cells by isoforms of human TACI. Blood. 2015;125:1749-58 pubmed 出版商
  279. Lehnhardt A, Strecker M, Eiermann T, Marget M, Thaiss F, Nashan B, et al. High B-cell activating factor is not associated with worse 3-year graft outcome in blood group-incompatible kidney transplantation with rituximab induction. Clin Transplant. 2015;29:359-64 pubmed 出版商
  280. Funakoshi S, Shimizu T, Numata O, Ato M, Melchers F, Ohnishi K. BILL-cadherin/cadherin-17 contributes to the survival of memory B cells. PLoS ONE. 2015;10:e0117566 pubmed 出版商
  281. de Masson A, Bouaziz J, Le Buanec H, Robin M, O Meara A, Parquet N, et al. CD24(hi)CD27⁺ and plasmablast-like regulatory B cells in human chronic graft-versus-host disease. Blood. 2015;125:1830-9 pubmed 出版商
  282. Johnson P, Challis R, Chowdhury F, Gao Y, Harvey M, Geldart T, et al. Clinical and biological effects of an agonist anti-CD40 antibody: a Cancer Research UK phase I study. Clin Cancer Res. 2015;21:1321-8 pubmed 出版商
  283. Li P, Feng L, Chen N, Ge X, Lv X, Lu K, et al. Metadherin contributes to the pathogenesis of chronic lymphocytic leukemia partially through Wnt/β-catenin pathway. Med Oncol. 2015;32:479 pubmed 出版商
  284. Afshar M, Richards S, Mann D, Cross A, Smith G, Netzer G, et al. Acute immunomodulatory effects of binge alcohol ingestion. Alcohol. 2015;49:57-64 pubmed 出版商
  285. Ito S, Barrett A, Dutra A, Pak E, Miner S, Keyvanfar K, et al. Long term maintenance of myeloid leukemic stem cells cultured with unrelated human mesenchymal stromal cells. Stem Cell Res. 2015;14:95-104 pubmed 出版商
  286. Bigley V, McGovern N, Milne P, Dickinson R, Pagan S, Cookson S, et al. Langerin-expressing dendritic cells in human tissues are related to CD1c+ dendritic cells and distinct from Langerhans cells and CD141high XCR1+ dendritic cells. J Leukoc Biol. 2015;97:627-34 pubmed 出版商
  287. Nemes E, Kagina B, Smit E, Africa H, Steyn M, Hanekom W, et al. Differential leukocyte counting and immunophenotyping in cryopreserved ex vivo whole blood. Cytometry A. 2015;87:157-65 pubmed 出版商
  288. Hagberg N, Theorell J, Hjorton K, Spee P, Eloranta M, Bryceson Y, et al. Functional anti-CD94/NKG2A and anti-CD94/NKG2C autoantibodies in patients with systemic lupus erythematosus. Arthritis Rheumatol. 2015;67:1000-11 pubmed 出版商
  289. Heninger A, Wentrup S, Al Saeedi M, Schiessling S, Giese T, Wartha F, et al. Immunomodulation of human intestinal T cells by the synthetic CD80 antagonist RhuDex®. Immun Inflamm Dis. 2014;2:166-80 pubmed 出版商
  290. Weihrauch M, Richly H, von Bergwelt Baildon M, Becker H, Schmidt M, Hacker U, et al. Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours. Eur J Cancer. 2015;51:146-56 pubmed 出版商
  291. Vadasz S, JENSEN T, Moncada C, Girard E, Zhang F, Blanchette A, et al. Second and third trimester amniotic fluid mesenchymal stem cells can repopulate a de-cellularized lung scaffold and express lung markers. J Pediatr Surg. 2014;49:1554-63 pubmed 出版商
  292. Van Eyck L, Hershfield M, Pombal D, Kelly S, Ganson N, Moens L, et al. Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency. J Allergy Clin Immunol. 2015;135:283-7.e5 pubmed 出版商
  293. Meinke P, Schneiderat P, Srsen V, Korfali N, Lê Thành P, Cowan G, et al. Abnormal proliferation and spontaneous differentiation of myoblasts from a symptomatic female carrier of X-linked Emery-Dreifuss muscular dystrophy. Neuromuscul Disord. 2015;25:127-36 pubmed 出版商
  294. Tungatt K, Bianchi V, Crowther M, Powell W, Schauenburg A, Trimby A, et al. Antibody stabilization of peptide-MHC multimers reveals functional T cells bearing extremely low-affinity TCRs. J Immunol. 2015;194:463-74 pubmed 出版商
  295. Chovancová J, Bernard T, Stehlíková O, Sálek D, Janíková A, Mayer J, et al. Detection of Minimal Residual Disease in Mantle Cell Lymphoma. Establishment of Novel 8-Color Flow Cytometry Approach. Cytometry B Clin Cytom. 2014;: pubmed 出版商
  296. Stacchini A, Pacchioni D, Demurtas A, Aliberti S, Cassenti A, Isolato G, et al. Utilility of flow cytometry as ancillary study to improve the cytologic diagnosis of thyroid lymphomas. Cytometry B Clin Cytom. 2015;88:320-9 pubmed 出版商
  297. Hautefort A, Girerd B, Montani D, Cohen Kaminsky S, Price L, Lambrecht B, et al. T-helper 17 cell polarization in pulmonary arterial hypertension. Chest. 2015;147:1610-1620 pubmed 出版商
  298. Sahler J, Woeller C, Phipps R. Microparticles engineered to highly express peroxisome proliferator-activated receptor-γ decreased inflammatory mediator production and increased adhesion of recipient monocytes. PLoS ONE. 2014;9:e113189 pubmed 出版商
  299. Williams D, Anastos K, Morgello S, Berman J. JAM-A and ALCAM are therapeutic targets to inhibit diapedesis across the BBB of CD14+CD16+ monocytes in HIV-infected individuals. J Leukoc Biol. 2015;97:401-12 pubmed 出版商
  300. Willmann K, Klaver S, DoÄŸu F, Santos Valente E, Garncarz W, Bilic I, et al. Biallelic loss-of-function mutation in NIK causes a primary immunodeficiency with multifaceted aberrant lymphoid immunity. Nat Commun. 2014;5:5360 pubmed 出版商
  301. Chow I, Yang J, Gates T, James E, Mai D, Greenbaum C, et al. Assessment of CD4+ T cell responses to glutamic acid decarboxylase 65 using DQ8 tetramers reveals a pathogenic role of GAD65 121-140 and GAD65 250-266 in T1D development. PLoS ONE. 2014;9:e112882 pubmed 出版商
  302. Kamburova E, Koenen H, van den Hoogen M, Baas M, Joosten I, Hilbrands L. Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapy. PLoS ONE. 2014;9:e112658 pubmed 出版商
  303. Thompson I, Mann E, Stokes M, English N, Knight S, Williamson D. Specific activation of dendritic cells enhances clearance of Bacillus anthracis following infection. PLoS ONE. 2014;9:e109720 pubmed 出版商
  304. Milne P, Bigley V, Gunawan M, Haniffa M, Collin M. CD1c+ blood dendritic cells have Langerhans cell potential. Blood. 2015;125:470-3 pubmed 出版商
  305. Maney N, Reynolds G, Krippner Heidenreich A, Hilkens C. Dendritic cell maturation and survival are differentially regulated by TNFR1 and TNFR2. J Immunol. 2014;193:4914-4923 pubmed 出版商
  306. Spaan M, Kreefft K, de Graav G, Brouwer W, de Knegt R, ten Kate F, et al. CD4+ CXCR5+ T cells in chronic HCV infection produce less IL-21, yet are efficient at supporting B cell responses. J Hepatol. 2015;62:303-10 pubmed 出版商
  307. Cucak H, Vistisen D, Witte D, Philipsen A, Rosendahl A. Reduction of specific circulating lymphocyte populations with metabolic risk factors in patients at risk to develop type 2 diabetes. PLoS ONE. 2014;9:e107140 pubmed 出版商
  308. Yu C, Becker C, Metang P, Marches F, Wang Y, Toshiyuki H, et al. Human CD141+ dendritic cells induce CD4+ T cells to produce type 2 cytokines. J Immunol. 2014;193:4335-43 pubmed 出版商
  309. Rasmussen S, Bilgrau A, Schmitz A, Falgreen S, Bergkvist K, Tramm A, et al. Stable Phenotype Of B-Cell Subsets Following Cryopreservation and Thawing of Normal Human Lymphocytes Stored in a Tissue Biobank. Cytometry B Clin Cytom. 2014;: pubmed 出版商
  310. Kurktschiev P, Raziorrouh B, Schraut W, Backmund M, Wächtler M, Wendtner C, et al. Dysfunctional CD8+ T cells in hepatitis B and C are characterized by a lack of antigen-specific T-bet induction. J Exp Med. 2014;211:2047-59 pubmed 出版商
  311. Hu H, Eller M, Zafar S, Zhou Y, Gu M, Wei Z, et al. Preferential infection of human Ad5-specific CD4 T cells by HIV in Ad5 naturally exposed and recombinant Ad5-HIV vaccinated individuals. Proc Natl Acad Sci U S A. 2014;111:13439-44 pubmed 出版商
  312. Toapanta F, Simon J, Barry E, Pasetti M, Levine M, Kotloff K, et al. Gut-Homing Conventional Plasmablasts and CD27(-) Plasmablasts Elicited after a Short Time of Exposure to an Oral Live-Attenuated Shigella Vaccine Candidate in Humans. Front Immunol. 2014;5:374 pubmed 出版商
  313. Chao Y, Kaliaperumal N, Chretien A, Tang S, Lee B, Poidinger M, et al. Human plasmacytoid dendritic cells regulate IFN-α production through activation-induced splicing of IL-18Rα. J Leukoc Biol. 2014;96:1037-46 pubmed 出版商
  314. Schneider Hohendorf T, Rossaint J, Mohan H, Böning D, Breuer J, Kuhlmann T, et al. VLA-4 blockade promotes differential routes into human CNS involving PSGL-1 rolling of T cells and MCAM-adhesion of TH17 cells. J Exp Med. 2014;211:1833-46 pubmed 出版商
  315. Arlehamn C, Seumois G, Gerasimova A, Huang C, Fu Z, Yue X, et al. Transcriptional profile of tuberculosis antigen-specific T cells reveals novel multifunctional features. J Immunol. 2014;193:2931-40 pubmed 出版商
  316. Meier D, Docena G, Ramisch D, Toscanini U, Berardi G, Gondolesi G, et al. Immunological status of isolated lymphoid follicles after intestinal transplantation. Am J Transplant. 2014;14:2148-58 pubmed 出版商
  317. Chung Y, Kim E, Abdel Wahab O. Femoral bone marrow aspiration in live mice. J Vis Exp. 2014;: pubmed 出版商
  318. Feng Y, Zhang N, Jacobs K, Jiang W, Yang L, Li Z, et al. Polarization imaging and classification of Jurkat T and Ramos B cells using a flow cytometer. Cytometry A. 2014;85:817-26 pubmed 出版商
  319. Lee Chang C, Bodogai M, Moritoh K, Olkhanud P, Chan A, Croft M, et al. Accumulation of 4-1BBL+ B cells in the elderly induces the generation of granzyme-B+ CD8+ T cells with potential antitumor activity. Blood. 2014;124:1450-9 pubmed 出版商
  320. Longman R, Diehl G, Victorio D, Huh J, Galan C, Miraldi E, et al. CX?CR1? mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22. J Exp Med. 2014;211:1571-83 pubmed 出版商
  321. Herrera A, Kim H, Bindra B, Jones K, Alyea E, Armand P, et al. A phase II study of bortezomib plus prednisone for initial therapy of chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2014;20:1737-43 pubmed 出版商
  322. Pegram H, Purdon T, van Leeuwen D, Curran K, Giralt S, Barker J, et al. IL-12-secreting CD19-targeted cord blood-derived T cells for the immunotherapy of B-cell acute lymphoblastic leukemia. Leukemia. 2015;29:415-22 pubmed 出版商
  323. Kobie J, Treanor J, Ritchlin C. Transient decrease in human peripheral blood myeloid dendritic cells following influenza vaccination correlates with induction of serum antibody. Immunol Invest. 2014;43:606-15 pubmed 出版商
  324. Gomez A, Willcox N, Vrolix K, Hummel J, Nogales Gadea G, Saxena A, et al. Proteasome inhibition with bortezomib depletes plasma cells and specific autoantibody production in primary thymic cell cultures from early-onset myasthenia gravis patients. J Immunol. 2014;193:1055-1063 pubmed 出版商
  325. Lepore M, de Lalla C, Gundimeda S, Gsellinger H, Consonni M, Garavaglia C, et al. A novel self-lipid antigen targets human T cells against CD1c(+) leukemias. J Exp Med. 2014;211:1363-77 pubmed 出版商
  326. Steinsbø Ø, Henry Dunand C, Huang M, Mesin L, Salgado Ferrer M, Lundin K, et al. Restricted VH/VL usage and limited mutations in gluten-specific IgA of coeliac disease lesion plasma cells. Nat Commun. 2014;5:4041 pubmed 出版商
  327. Jitschin R, Braun M, Büttner M, Dettmer Wilde K, Bricks J, Berger J, et al. CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs. Blood. 2014;124:750-60 pubmed 出版商
  328. Stimpfel M, Cerkovnik P, Novakovic S, Maver A, Virant Klun I. Putative mesenchymal stem cells isolated from adult human ovaries. J Assist Reprod Genet. 2014;31:959-74 pubmed 出版商
  329. Rossi E, Chang C, Goldenberg D. Anti-CD22/CD20 Bispecific antibody with enhanced trogocytosis for treatment of Lupus. PLoS ONE. 2014;9:e98315 pubmed 出版商
  330. Weber G, Chousterman B, Hilgendorf I, Robbins C, Theurl I, Gerhardt L, et al. Pleural innate response activator B cells protect against pneumonia via a GM-CSF-IgM axis. J Exp Med. 2014;211:1243-56 pubmed 出版商
  331. Demberg T, Mohanram V, Venzon D, Robert Guroff M. Phenotypes and distribution of mucosal memory B-cell populations in the SIV/SHIV rhesus macaque model. Clin Immunol. 2014;153:264-76 pubmed 出版商
  332. Wilson E, Singh A, Hullsiek K, Gibson D, Henry W, Lichtenstein K, et al. Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infection. J Infect Dis. 2014;210:1396-406 pubmed 出版商
  333. Barbosa R, Silva S, Silva S, Melo A, Pereira Santos M, Barata J, et al. Reduced BAFF-R and increased TACI expression in common variable immunodeficiency. J Clin Immunol. 2014;34:573-83 pubmed 出版商
  334. Tarbox J, Keppel M, Topcagic N, Mackin C, Ben Abdallah M, Baszis K, et al. Elevated double negative T cells in pediatric autoimmunity. J Clin Immunol. 2014;34:594-9 pubmed 出版商
  335. Schuler P, Saze Z, Hong C, Muller L, Gillespie D, Cheng D, et al. Human CD4+ CD39+ regulatory T cells produce adenosine upon co-expression of surface CD73 or contact with CD73+ exosomes or CD73+ cells. Clin Exp Immunol. 2014;177:531-43 pubmed 出版商
  336. Cartellieri M, Koristka S, Arndt C, Feldmann A, Stamova S, von Bonin M, et al. A novel ex vivo isolation and expansion procedure for chimeric antigen receptor engrafted human T cells. PLoS ONE. 2014;9:e93745 pubmed 出版商
  337. Itoua Maïga R, Lemieux J, Roy A, Simard C, Néron S. Flow cytometry assessment of in vitro generated CD138+ human plasma cells. Biomed Res Int. 2014;2014:536482 pubmed 出版商
  338. Prinz P, Mendler A, Brech D, Masouris I, Oberneder R, Noessner E. NK-cell dysfunction in human renal carcinoma reveals diacylglycerol kinase as key regulator and target for therapeutic intervention. Int J Cancer. 2014;135:1832-41 pubmed 出版商
  339. Le Saout C, Hasley R, Imamichi H, Tcheung L, Hu Z, Luckey M, et al. Chronic exposure to type-I IFN under lymphopenic conditions alters CD4 T cell homeostasis. PLoS Pathog. 2014;10:e1003976 pubmed 出版商
  340. Magri G, Miyajima M, Bascones S, Mortha A, Puga I, Cassis L, et al. Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells. Nat Immunol. 2014;15:354-364 pubmed 出版商
  341. Ilander M, Kreutzman A, Rohon P, Melo T, Faber E, Porkka K, et al. Enlarged memory T-cell pool and enhanced Th1-type responses in chronic myeloid leukemia patients who have successfully discontinued IFN-? monotherapy. PLoS ONE. 2014;9:e87794 pubmed 出版商
  342. Nikitin P, Price A, McFadden K, Yan C, Luftig M. Mitogen-induced B-cell proliferation activates Chk2-dependent G1/S cell cycle arrest. PLoS ONE. 2014;9:e87299 pubmed 出版商
  343. Sereti I, Estes J, Thompson W, Morcock D, Fischl M, Croughs T, et al. Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration. PLoS Pathog. 2014;10:e1003890 pubmed 出版商
  344. Ataide M, Andrade W, Zamboni D, Wang D, Souza M, Franklin B, et al. Malaria-induced NLRP12/NLRP3-dependent caspase-1 activation mediates inflammation and hypersensitivity to bacterial superinfection. PLoS Pathog. 2014;10:e1003885 pubmed 出版商
  345. Doi H, Tanoue S, Kaplan D. Peripheral CD27-CD21- B-cells represent an exhausted lymphocyte population in hepatitis C cirrhosis. Clin Immunol. 2014;150:184-91 pubmed 出版商
  346. Kim H, Lee H, Chang Y, Pichavant M, Shore S, Fitzgerald K, et al. Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity. Nat Med. 2014;20:54-61 pubmed 出版商
  347. Galindo Albarrán A, Ramirez Pliego O, Labastida Conde R, Melchy Pérez E, Liquitaya Montiel A, Esquivel Guadarrama F, et al. CD43 signals prepare human T cells to receive cytokine differentiation signals. J Cell Physiol. 2014;229:172-80 pubmed
  348. Herting F, Friess T, Bader S, Muth G, Hölzlwimmer G, Rieder N, et al. Enhanced anti-tumor activity of the glycoengineered type II CD20 antibody obinutuzumab (GA101) in combination with chemotherapy in xenograft models of human lymphoma. Leuk Lymphoma. 2014;55:2151-5160 pubmed 出版商
  349. Elias S, Choudhary P, de Cassan S, Biswas S, Collins K, Halstead F, et al. Analysis of human B-cell responses following ChAd63-MVA MSP1 and AMA1 immunization and controlled malaria infection. Immunology. 2014;141:628-44 pubmed 出版商
  350. Krishnan S, Wilson E, Sheikh V, Rupert A, Mendoza D, Yang J, et al. Evidence for innate immune system activation in HIV type 1-infected elite controllers. J Infect Dis. 2014;209:931-9 pubmed 出版商
  351. Adams R, Cheung C, Banh R, Saal R, Cross D, Gill D, et al. Prognostic value of ZAP-70 expression in chronic lymphocytic leukemia as assessed by quantitative polymerase chain reaction and flow cytometry. Cytometry B Clin Cytom. 2014;86:80-90 pubmed
  352. Miyashita T, Kimura K, Fukami T, Nakajima M, Yokoi T. Evaluation and mechanistic analysis of the cytotoxicity of the acyl glucuronide of nonsteroidal anti-inflammatory drugs. Drug Metab Dispos. 2014;42:1-8 pubmed 出版商
  353. Lighaam L, Vermeulen E, Bleker T, Meijlink K, Aalberse R, Barnes E, et al. Phenotypic differences between IgG4+ and IgG1+ B cells point to distinct regulation of the IgG4 response. J Allergy Clin Immunol. 2014;133:267-70.e1-6 pubmed 出版商
  354. Raghunathan R, Mahesula S, Kancharla K, Janardhanan P, Jadhav Y, Nadeau R, et al. Anti-CRLF2 Antibody-Armored Biodegradable Nanoparticles for Childhood B-ALL. Part Part Syst Charact. 2013;30:355-364 pubmed
  355. Bittner S, Ruck T, Schuhmann M, Herrmann A, Moha Ou Maati H, Bobak N, et al. Endothelial TWIK-related potassium channel-1 (TREK1) regulates immune-cell trafficking into the CNS. Nat Med. 2013;19:1161-5 pubmed 出版商
  356. Barua S, Iyer J, Larabee J, Raisley B, Hughes M, Coggeshall K, et al. Toxin inhibition of antimicrobial factors induced by Bacillus anthracis peptidoglycan in human blood. Infect Immun. 2013;81:3693-702 pubmed 出版商
  357. Stacchini A, Aliberti S, Pacchioni D, Demurtas A, Isolato G, Gazzera C, et al. Flow cytometry significantly improves the diagnostic value of fine needle aspiration cytology of lymphoproliferative lesions of salivary glands. Cytopathology. 2014;25:231-40 pubmed 出版商
  358. Pala P, Serwanga J, Watera C, Ritchie A, Moodie Z, Wang M, et al. Quantitative and qualitative differences in the T cell response to HIV in uninfected Ugandans exposed or unexposed to HIV-infected partners. J Virol. 2013;87:9053-63 pubmed 出版商
  359. Greig B, Stetler Stevenson M, Lea J. Stabilization media increases recovery in paucicellular cerebrospinal fluid specimens submitted for flow cytometry testing. Cytometry B Clin Cytom. 2014;86:135-8 pubmed 出版商
  360. Parzych E, Li H, Yin X, Liu Q, Wu T, Podsakoff G, et al. Effects of immunosuppression on circulating adeno-associated virus capsid-specific T cells in humans. Hum Gene Ther. 2013;24:431-42 pubmed 出版商
  361. Palin A, Ramachandran V, Acharya S, Lewis D. Human neonatal naive CD4+ T cells have enhanced activation-dependent signaling regulated by the microRNA miR-181a. J Immunol. 2013;190:2682-91 pubmed 出版商
  362. De Oliveira S, Wang J, Ryan C, Morrison S, Kohn D, Hollis R. A CD19/Fc fusion protein for detection of anti-CD19 chimeric antigen receptors. J Transl Med. 2013;11:23 pubmed 出版商
  363. Gaur R, Suhosk M, Banaei N. In vitro immunomodulation of a whole blood IFN-? release assay enhances T cell responses in subjects with latent tuberculosis infection. PLoS ONE. 2012;7:e48027 pubmed 出版商
  364. Patel A, Vargas V, Revello P, Bull D. Mesenchymal stem cell population isolated from the subepithelial layer of umbilical cord tissue. Cell Transplant. 2013;22:513-9 pubmed 出版商
  365. Ekeruche Makinde J, Clement M, Cole D, Edwards E, Ladell K, Miles J, et al. T-cell receptor-optimized peptide skewing of the T-cell repertoire can enhance antigen targeting. J Biol Chem. 2012;287:37269-81 pubmed 出版商
  366. Kvistborg P, Shu C, Heemskerk B, Fankhauser M, Thrue C, Toebes M, et al. TIL therapy broadens the tumor-reactive CD8(+) T cell compartment in melanoma patients. Oncoimmunology. 2012;1:409-418 pubmed
  367. Qi Y, Operario D, Georas S, Mosmann T. The acute environment, rather than T cell subset pre-commitment, regulates expression of the human T cell cytokine amphiregulin. PLoS ONE. 2012;7:e39072 pubmed 出版商
  368. McArthur M, Sztein M. Heterogeneity of multifunctional IL-17A producing S. Typhi-specific CD8+ T cells in volunteers following Ty21a typhoid immunization. PLoS ONE. 2012;7:e38408 pubmed 出版商
  369. Dorvignit D, Palacios J, Merino M, Hernández T, Sosa K, Casaco A, et al. Expression and biological characterization of an anti-CD20 biosimilar candidate antibody: a case study. MAbs. 2012;4:488-96 pubmed 出版商
  370. Lyke K, Dabo A, Arama C, Daou M, Diarra I, Wang A, et al. Reduced T regulatory cell response during acute Plasmodium falciparum infection in Malian children co-infected with Schistosoma haematobium. PLoS ONE. 2012;7:e31647 pubmed 出版商
  371. Man S, Tucky B, Cotleur A, Drazba J, Takeshita Y, Ransohoff R. CXCL12-induced monocyte-endothelial interactions promote lymphocyte transmigration across an in vitro blood-brain barrier. Sci Transl Med. 2012;4:119ra14 pubmed 出版商
  372. Frasca D, Diaz A, Romero M, Phillips M, Mendez N, Landin A, et al. Unique biomarkers for B-cell function predict the serum response to pandemic H1N1 influenza vaccine. Int Immunol. 2012;24:175-82 pubmed 出版商
  373. Hirao L, Hokey D, Morrow M, Jure Kunkel M, Weiner D. Immune modulation through 4-1BB enhances SIV vaccine protection in non-human primates against SIVmac251 challenge. PLoS ONE. 2011;6:e24250 pubmed 出版商
  374. Luiza Silva M, Campi Azevedo A, Batista M, Martins M, Avelar R, da Silveira Lemos D, et al. Cytokine signatures of innate and adaptive immunity in 17DD yellow fever vaccinated children and its association with the level of neutralizing antibody. J Infect Dis. 2011;204:873-83 pubmed 出版商
  375. Clement M, Ladell K, Ekeruche Makinde J, Miles J, Edwards E, Dolton G, et al. Anti-CD8 antibodies can trigger CD8+ T cell effector function in the absence of TCR engagement and improve peptide-MHCI tetramer staining. J Immunol. 2011;187:654-63 pubmed 出版商
  376. Li H, Lasaro M, Jia B, Lin S, Haut L, High K, et al. Capsid-specific T-cell responses to natural infections with adeno-associated viruses in humans differ from those of nonhuman primates. Mol Ther. 2011;19:2021-30 pubmed 出版商
  377. Lee J, Hayman E, Pegram H, Santos E, Heller G, Sadelain M, et al. In vivo inhibition of human CD19-targeted effector T cells by natural T regulatory cells in a xenotransplant murine model of B cell malignancy. Cancer Res. 2011;71:2871-81 pubmed 出版商
  378. Berthoud T, Hamill M, Lillie P, Hwenda L, Collins K, Ewer K, et al. Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1. Clin Infect Dis. 2011;52:1-7 pubmed 出版商
  379. Mizuochi T, Ito M, Takai K, Yamaguchi K. Peripheral blood memory B cells are resistant to apoptosis in chronic hepatitis C patients. Virus Res. 2011;155:349-51 pubmed 出版商
  380. Rawstron A, Shingles J, de Tute R, Bennett F, Jack A, Hillmen P. Chronic lymphocytic leukaemia (CLL) and CLL-type monoclonal B-cell lymphocytosis (MBL) show differential expression of molecules involved in lymphoid tissue homing. Cytometry B Clin Cytom. 2010;78 Suppl 1:S42-6 pubmed 出版商
  381. Polson A, Williams M, Gray A, Fuji R, Poon K, McBride J, et al. Anti-CD22-MCC-DM1: an antibody-drug conjugate with a stable linker for the treatment of non-Hodgkin's lymphoma. Leukemia. 2010;24:1566-73 pubmed 出版商
  382. Mizuochi T, Ito M, Saito K, Kasai M, Kunimura T, Morohoshi T, et al. Possible recruitment of peripheral blood CXCR3+ CD27+ CD19+ B cells to the liver of chronic hepatitis C patients. J Interferon Cytokine Res. 2010;30:243-52 pubmed 出版商
  383. Schmetterer K, Seidel M, Körmöczi U, Rottal A, Schwarz K, Matthes Martin S, et al. Two newly diagnosed HLA class II-deficient patients identified by rapid vector-based complementation analysis reveal discoordinate invariant chain expression levels. Int Arch Allergy Immunol. 2010;152:390-400 pubmed 出版商
  384. Fung E, Esposito L, Todd J, Wicker L. Multiplexed immunophenotyping of human antigen-presenting cells in whole blood by polychromatic flow cytometry. Nat Protoc. 2010;5:357-70 pubmed 出版商
  385. Marino J, Tan C, Taylor A, Bentley C, Van De Wiele C, Ranne R, et al. Differential IL-7 responses in developing human thymocytes. Hum Immunol. 2010;71:329-33 pubmed 出版商
  386. Erlendsson L, Muench M, Hellman U, Hrafnkelsdóttir S, Jonsson A, Balmer Y, et al. Barley as a green factory for the production of functional Flt3 ligand. Biotechnol J. 2010;5:163-71 pubmed 出版商
  387. Mizuochi T, Ito M, Takai K, Yamaguchi K. Differential susceptibility of peripheral blood CD5+ and CD5- B cells to apoptosis in chronic hepatitis C patients. Biochem Biophys Res Commun. 2009;389:512-5 pubmed 出版商
  388. Göbel F, Taschner S, Jurkin J, Konradi S, Vaculik C, Richter S, et al. Reciprocal role of GATA-1 and vitamin D receptor in human myeloid dendritic cell differentiation. Blood. 2009;114:3813-21 pubmed 出版商
  389. Silva S, Sousa A, Haddad A, Azevedo J, Soares V, Peixoto C, et al. Autologous bone-marrow mononuclear cell transplantation after acute myocardial infarction: comparison of two delivery techniques. Cell Transplant. 2009;18:343-52 pubmed 出版商
  390. Strickland L, Ross J, Williams S, Ross S, Romero M, Spencer S, et al. Preclinical evaluation of carcinoembryonic cell adhesion molecule (CEACAM) 6 as potential therapy target for pancreatic adenocarcinoma. J Pathol. 2009;218:380-90 pubmed 出版商
  391. Hokey D, Yan J, Hirao L, Dai A, Boyer J, Jure Kunkel M, et al. CLTA-4 blockade in vivo promotes the generation of short-lived effector CD8 T cells and a more persistent central memory CD4 T cell response. J Med Primatol. 2008;37 Suppl 2:62-8 pubmed 出版商
  392. Park C, Majeti R, Weissman I. In vivo evaluation of human hematopoiesis through xenotransplantation of purified hematopoietic stem cells from umbilical cord blood. Nat Protoc. 2008;3:1932-40 pubmed 出版商
  393. Wang J, Kobie J, Zhang L, Cochran M, Mosmann T, Ritchlin C, et al. An 11-color flow cytometric assay for identifying, phenotyping, and assessing endocytic ability of peripheral blood dendritic cell subsets in a single platform. J Immunol Methods. 2009;341:106-16 pubmed 出版商
  394. Morbach H, Richl P, Faber C, Singh S, Girschick H. The kappa immunoglobulin light chain repertoire of peripheral blood B cells in patients with juvenile rheumatoid arthritis. Mol Immunol. 2008;45:3840-6 pubmed 出版商
  395. Giannelli S, Taddeo A, Presicce P, Villa M, Della Bella S. A six-color flow cytometric assay for the analysis of peripheral blood dendritic cells. Cytometry B Clin Cytom. 2008;74:349-55 pubmed 出版商
  396. Gurer C, Strowig T, Brilot F, Pack M, Trumpfheller C, Arrey F, et al. Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses. Blood. 2008;112:1231-9 pubmed 出版商
  397. Hokey D, Johnson F, Smith J, Weber J, Yan J, Hirao L, et al. Activation drives PD-1 expression during vaccine-specific proliferation and following lentiviral infection in macaques. Eur J Immunol. 2008;38:1435-45 pubmed 出版商
  398. Sathler Avelar R, Vitelli Avelar D, Massara R, de Lana M, Pinto Dias J, Teixeira Carvalho A, et al. Etiological treatment during early chronic indeterminate Chagas disease incites an activated status on innate and adaptive immunity associated with a type 1-modulated cytokine pattern. Microbes Infect. 2008;10:103-13 pubmed 出版商
  399. Suva D, Passweg J, Arnaudeau S, Hoffmeyer P, Kindler V. In vitro activated human T lymphocytes very efficiently attach to allogenic multipotent mesenchymal stromal cells and transmigrate under them. J Cell Physiol. 2008;214:588-94 pubmed
  400. Martins M, Silva M, Marciano A, Peruhype Magalhães V, Eloi Santos S, Ribeiro J, et al. Activation/modulation of adaptive immunity emerges simultaneously after 17DD yellow fever first-time vaccination: is this the key to prevent severe adverse reactions following immunization?. Clin Exp Immunol. 2007;148:90-100 pubmed
  401. Diaz Blanco E, Bruns I, Neumann F, Fischer J, Graef T, Rosskopf M, et al. Molecular signature of CD34(+) hematopoietic stem and progenitor cells of patients with CML in chronic phase. Leukemia. 2007;21:494-504 pubmed
  402. Kolar G, Mehta D, Pelayo R, Capra J. A novel human B cell subpopulation representing the initial germinal center population to express AID. Blood. 2007;109:2545-52 pubmed
  403. Gattorno M, Chicha L, Gregorio A, Ferlito F, Rossi F, Jarrossay D, et al. Distinct expression pattern of IFN-alpha and TNF-alpha in juvenile idiopathic arthritis synovial tissue. Rheumatology (Oxford). 2007;46:657-65 pubmed
  404. Williams M, Densmore J, Pawluczkowycz A, Beum P, Kennedy A, Lindorfer M, et al. Thrice-weekly low-dose rituximab decreases CD20 loss via shaving and promotes enhanced targeting in chronic lymphocytic leukemia. J Immunol. 2006;177:7435-43 pubmed
  405. Kolar G, Mehta D, Wilson P, Capra J. Diversity of the Ig repertoire is maintained with age in spite of reduced germinal centre cells in human tonsil lymphoid tissue. Scand J Immunol. 2006;64:314-24 pubmed
  406. Bojarska Junak A, Giannopoulos K, Kowal M, Dmoszynska A, Rolinski J. Comparison of methods for determining zeta-chain associated protein - 70 (ZAP-70) expression in patients with B-cell chronic lymphocytic leukemia (B-CLL). Cytometry B Clin Cytom. 2006;70:293-301 pubmed
  407. Hillyard D, Nutt C, Thomson J, McDonald K, Wan R, Cameron A, et al. Statins inhibit NK cell cytotoxicity by membrane raft depletion rather than inhibition of isoprenylation. Atherosclerosis. 2007;191:319-25 pubmed
  408. Campbell R, Manyak S, Yang H, Sjak Shie N, Chen H, Gui D, et al. LAGlambda-1: a clinically relevant drug resistant human multiple myeloma tumor murine model that enables rapid evaluation of treatments for multiple myeloma. Int J Oncol. 2006;28:1409-17 pubmed
  409. Jamieson C, Gotlib J, Durocher J, Chao M, Mariappan M, Lay M, et al. The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation. Proc Natl Acad Sci U S A. 2006;103:6224-9 pubmed
  410. Timeus F, Crescenzio N, Sanavio F, Fazio L, Doria A, Foglia L, et al. Multilineage engraftment of refrozen cord blood hematopoietic progenitors in NOD/SCID mice. Haematologica. 2006;91:369-72 pubmed
  411. Infantino S, Moepps B, Thelen M. Expression and regulation of the orphan receptor RDC1 and its putative ligand in human dendritic and B cells. J Immunol. 2006;176:2197-207 pubmed
  412. Olivier A, Lauret E, Gonin P, Galy A. The Notch ligand delta-1 is a hematopoietic development cofactor for plasmacytoid dendritic cells. Blood. 2006;107:2694-701 pubmed
  413. Lopez Santalla M, Valeri A, Perez Blas M, Aguilera Montilla N, Gutierrez A, Lasa I, et al. Expression of CD45 and proliferative response to CD3 as suitable classification markers of patients with gastric adenocarcinoma. Cancer Immunol Immunother. 2006;55:744-8 pubmed
  414. Siliciano J, Siliciano R. Enhanced culture assay for detection and quantitation of latently infected, resting CD4+ T-cells carrying replication-competent virus in HIV-1-infected individuals. Methods Mol Biol. 2005;304:3-15 pubmed
  415. Mittag A, Lenz D, Gerstner A, Sack U, Steinbrecher M, Koksch M, et al. Polychromatic (eight-color) slide-based cytometry for the phenotyping of leukocyte, NK, and NKT subsets. Cytometry A. 2005;65:103-15 pubmed
  416. Aguilera Montilla N, Perez Blas M, Valeri A, Lopez Santalla M, Rodríguez Juan C, Mencia A, et al. Higher proliferative capacity of T lymphocytes from patients with Crohn disease than from ulcerative colitis is disclosed by use of Herpesvirus saimiri-transformed T-cell lines. Scand J Gastroenterol. 2004;39:1236-42 pubmed
  417. Ku C, Zerboni L, Ito H, Graham B, Wallace M, Arvin A. Varicella-zoster virus transfer to skin by T Cells and modulation of viral replication by epidermal cell interferon-alpha. J Exp Med. 2004;200:917-25 pubmed
  418. Perin E, Dohmann H, Borojevic R, Silva S, Sousa A, Silva G, et al. Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy. Circulation. 2004;110:II213-8 pubmed
  419. Lee J, Sait S, Wetzler M. Characterization of dendritic-like cells derived from t(9;22) acute lymphoblastic leukemia blasts. Int Immunol. 2004;16:1377-89 pubmed
  420. Hillyard D, Cameron A, McDonald K, Thomson J, MacIntyre A, Shiels P, et al. Simvastatin inhibits lymphocyte function in normal subjects and patients with cardiovascular disease. Atherosclerosis. 2004;175:305-13 pubmed
  421. Kolar G, Yokota T, Rossi M, Nath S, Capra J. Human fetal, cord blood, and adult lymphocyte progenitors have similar potential for generating B cells with a diverse immunoglobulin repertoire. Blood. 2004;104:2981-7 pubmed
  422. Tan P, Chan C, Xue S, Dong R, Ananthesayanan B, Manunta M, et al. Phenotypic and functional differences between human saphenous vein (HSVEC) and umbilical vein (HUVEC) endothelial cells. Atherosclerosis. 2004;173:171-83 pubmed
  423. del Giudice I, Matutes E, Morilla R, Morilla A, Owusu Ankomah K, Rafiq F, et al. The diagnostic value of CD123 in B-cell disorders with hairy or villous lymphocytes. Haematologica. 2004;89:303-8 pubmed
  424. Yokota T, Meka C, Kouro T, Medina K, Igarashi H, Takahashi M, et al. Adiponectin, a fat cell product, influences the earliest lymphocyte precursors in bone marrow cultures by activation of the cyclooxygenase-prostaglandin pathway in stromal cells. J Immunol. 2003;171:5091-9 pubmed
  425. Valeri A, Perez Blas M, Gutierrez A, Lopez Santalla M, Aguilera N, Rodríguez Juan C, et al. Intrinsic defects explain altered proliferative responses of T lymphocytes and HVS-derived T-cell lines in gastric adenocarcinoma. Cancer Immunol Immunother. 2003;52:708-14 pubmed
  426. Kivisakk P, Mahad D, Callahan M, Trebst C, Tucky B, Wei T, et al. Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin. Proc Natl Acad Sci U S A. 2003;100:8389-94 pubmed
  427. Stacchini A, Demurtas A, Godio L, Martini G, Antinoro V, Palestro G. Flow cytometry in the bone marrow staging of mature B-cell neoplasms. Cytometry B Clin Cytom. 2003;54:10-8 pubmed
  428. McIlroy D, Troadec C, Grassi F, Samri A, Barrou B, Autran B, et al. Investigation of human spleen dendritic cell phenotype and distribution reveals evidence of in vivo activation in a subset of organ donors. Blood. 2001;97:3470-7 pubmed
  429. Agrawal S, Marquet J, Plumas J, Rouard H, Delfau Larue M, Gaulard P, et al. Multiple co-stimulatory signals are required for triggering proliferation of T cells from human secondary lymphoid tissue. Int Immunol. 2001;13:441-50 pubmed
  430. Sharron M, Pohlmann S, Price K, Lolis E, Tsang M, Kirchhoff F, et al. Expression and coreceptor activity of STRL33/Bonzo on primary peripheral blood lymphocytes. Blood. 2000;96:41-9 pubmed
  431. Minguela A, Marin L, Torio A, Muro M, Garcia Alonso A, Moya Quiles M, et al. CD28/CTLA-4 and CD80/CD86 costimulatory molecules are mainly involved in acceptance or rejection of human liver transplant. Hum Immunol. 2000;61:658-69 pubmed
  432. Eksioglu Demiralp E, Budak Alpdogan T, Alpdogan O, Atalay A, Ratip S, Oz D, et al. Double G0/G1 peak in the DNA histogram of aberrant marker positive acute leukemia patients is associated with a poor clinical outcome. Leuk Lymphoma. 1999;33:567-72 pubmed
  433. Cabezudo E, Carrara P, Morilla R, Matutes E. Quantitative analysis of CD79b, CD5 and CD19 in mature B-cell lymphoproliferative disorders. Haematologica. 1999;84:413-8 pubmed
  434. Nomdedeu J, Mateu R, Altes A, Llorente A, Rio C, Estivill C, et al. Enhanced myeloid specificity of CD117 compared with CD13 and CD33. Leuk Res. 1999;23:341-7 pubmed
  435. Muench M, Roncarolo M, Menon S, Xu Y, Kastelein R, Zurawski S, et al. FLK-2/FLT-3 ligand regulates the growth of early myeloid progenitors isolated from human fetal liver. Blood. 1995;85:963-72 pubmed